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A B S T R A C T
Background
Women with a prior caesarean delivery have an increased risk of uterine rupture and for women subsequently requiring induction of labour
it is unclear which method is preferable to avoid adverse outcomes. This is an update of a review that was published in 2013.
Objectives
To assess the benefits and harms associated with different methods used to induce labour in women who have had a previous caesarean
birth.
Search methods
We searched Cochrane Pregnancy and Childbirth's Trials Register (31 August 2016) and reference lists of retrieved studies.
Selection criteria
Randomised controlled trials (RCTs) comparing any method of third trimester cervical ripening or labour induction, with placebo/no treat-
ment or other methods in women with prior caesarean section requiring labour induction in a subsequent pregnancy.
Data collection and analysis
Two review authors independently assessed studies for inclusion and trial quality, extracted data, and checked them for accuracy.
Main results
Eight studies (data from 707 women and babies) are included in this updated review. Meta-analysis was not possible because studies com-
pared different methods of labour induction. All included studies had at least one design limitation (i.e. lack of blinding, sample attrition,
other bias, or reporting bias). One study stopped prematurely due to safety concerns.
Vaginal PGE2 versus intravenous oxytocin (one trial, 42 women): no clear differences for caesarean section (risk ratio (RR) 0.67, 95%
confidence interval (CI) 0.22 to 2.03, evidence graded low), serious neonatal morbidity or perinatal death (RR 3.00, 95% CI 0.13 to 69.70,
evidence graded low), serious maternal morbidity or death (RR 3.00, 95% CI 0.13 to 69.70, evidence graded low). Also no clear differences
between groups for the reported secondary outcomes. The GRADE outcomes vaginal delivery not achieved within 24 hours, and uterine
hyperstimulation with fetal heart rate changes were not reported.
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Vaginal misoprostol versus intravenous oxytocin (one trial, 38 women): this trial stopped early because one woman who received miso-
prostol had a uterine rupture (RR 3.67, 95% CI 0.16 to 84.66) and one had uterine dehiscence. No other outcomes (including GRADE out-
comes) were reported.
Foley catheter versus intravenous oxytocin (one trial, subgroup of 53 women): no clear difference between groups for vaginal delivery
not achieved within 24 hours (RR 1.47, 95% CI 0.89 to 2.44, evidence graded low), uterine hyperstimulation with fetal heart rate changes
(RR 3.11, 95% CI 0.13 to 73.09, evidence graded low), and caesarean section (RR 0.93, 95% CI 0.45 to 1.92, evidence graded low). There
were also no clear differences between groups for the reported secondary outcomes. The following GRADE outcomes were not reported:
serious neonatal morbidity or perinatal death, and serious maternal morbidity or death.
Double-balloon catheter versus vaginal PGE2 (one trial, subgroup of 26 women): no clear difference in caesarean section (RR 0.97, 95%
CI 0.41 to 2.32, evidence graded very low). Vaginal delivery not achieved within 24 hours, uterine hyperstimulation with fetal heart rate
changes, serious neonatal morbidity or perinatal death, and serious maternal morbidity or death were not reported.
Oral mifepristone versus Foley catheter (one trial, 107 women): no primary/GRADE outcomes were reported. Fewer women induced
with mifepristone required oxytocin augmentation (RR 0.54, 95% CI 0.38 to 0.76). There were slightly fewer cases of uterine rupture among
women who received mifepristone, however this was not a clear difference between groups (RR 0.29, 95% CI 0.08 to 1.02). No other sec-
ondary outcomes were reported.
Vaginal isosorbide mononitrate (IMN) versus Foley catheter (one trial, 80 women): fewer women induced with IMN achieved a vaginal
delivery within 24 hours (RR 2.62, 95% CI 1.32 to 5.21, evidence graded low). There was no difference between groups in the number of
women who had a caesarean section (RR 1.00, 95% CI 0.39 to 2.59, evidence graded very low). More women induced with IMN required
oxytocin augmentation (RR 1.65, 95% CI 1.17 to 2.32). There were no clear differences in the other reported secondary outcomes. The
following GRADE outcomes were not reported: uterine hyperstimulation with fetal heart rate changes, serious neonatal morbidity or peri-
natal death, and serious maternal morbidity or death.
80 mL versus 30 mL Foley catheter (one trial, 154 women): no clear difference between groups for the primary outcomes: vaginal delivery
not achieved within 24 hours (RR 1.05, 95% CI 0.91 to 1.20, evidence graded moderate) and caesarean section (RR 1.05, 95% CI 0.89 to 1.24,
evidence graded moderate). However, more women induced using a 30 mL Foley catheter required oxytocin augmentation (RR 0.81, 95%
CI 0.66 to 0.98). There were no clear differences between groups for other secondary outcomes reported. Several GRADE outcomes were
not reported: uterine hyperstimulation with fetal heart rate changes, serious neonatal morbidity or perinatal death, and serious maternal
morbidity or death.
Vaginal PGE2 pessary versus vaginal PGE2 tablet (one trial, 200 women): no difference between groups for caesarean section (RR 1.09,
95% CI 0.74 to 1.60, evidence graded very low), or any of the reported secondary outcomes. Several GRADE outcomes were not reported:
vaginal delivery not achieved within 24 hours, uterine hyperstimulation with fetal heart rate changes, serious neonatal morbidity or peri-
natal death, and serious maternal morbidity or death.
Authors' conclusions
RCT evidence on methods of induction of labour for women with a prior caesarean section is inadequate, and studies are underpowered
to detect clinically relevant differences for many outcomes. Several studies reported few of our prespecified outcomes and reporting of
infant outcomes was especially scarce. The GRADE level for quality of evidence was moderate to very low, due to imprecision and study
design limitations.
High-quality, adequately-powered RCTs would be the best approach to determine the optimal method for induction of labour in women
with a prior caesarean birth. However, such trials are unlikely to be undertaken due to the very large numbers needed to investigate the
risk of infrequent but serious adverse outcomes (e.g. uterine rupture). Observational studies (cohort studies), including different methods
of cervical ripening, may be the best alternative. Studies could compare methods believed to provide effective induction of labour with
low risk of serious harm, and report the outcomes listed in this review.
P L A I N   L A N G U A G E   S U M M A R Y
Induction methods for women who have had a prior caesarean birth
What is the issue?
Labour induction is a common procedure, carried out when it is judged to be safer for a baby to be born than to continue a pregnancy.
When a woman who has had a caesarean in the past gives birth, current clinical practice supports helping her to have a vaginal birth.
However, there is a higher risk of complications from induction for women who have previously had a caesarean section.
Methods for induction include: prostaglandin medication (including oral or vaginal prostaglandins E2 (PGE2) or misoprostol); mifepristone;
mechanical methods (including Foley catheters and double-balloon catheters); nitric oxide donors (such as isosorbide mononitrate); and
oxytocin. This review looked at the harms and benefits of different methods for induction of labour in women with a prior caesarean birth,
if induction of labour was required in their current pregnancy.
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Why is this important?
Lots of women have caesareans: across the world between one in four and one in two babies are born by caesarean section. Many women
go on to have another pregnancy, and we want to know how to deliver these babies safely. Women with a prior caesarean birth have
an increased risk of uterine scar rupture, particularly when labour is induced. This is a serious complication, often leading to negative
outcomes for mother and child, such as hysterectomy, genitourinary tract injury, and postpartum blood transfusions for the mother, and
neurological impairment or even death for the child.
What evidence did we find?
We searched for studies on 31 August 2016. Eight small randomised controlled trials are included in this updated review, with data from
707 women and babies. The studies compared different methods of inducing labour, so results could not be combined.
There were design problems in all of the trials: women and health professionals knew which induction method was being used in seven
out of eight trials, which may have affected clinical decisions. Women were leN out of the analysis in some trials, and trials often did not
report important outcomes (vaginal birth not achieved within 24 hours of induction, overstimulation of the uterus with changes to the
baby's heart rate, caesarean section, serious illness or death of the baby, serious illness or death of the mother).
The trials were too small to show clear differences. The quality of the evidence was very low, low, or moderate, because the trials were
small and had high risk of bias. We cannot be certain about the results, and future research may show something different.
What does this mean?
There is not enough information available from randomised controlled trials to advise on the best methods of labour induction in women
with a previous caesarean birth. More high-quality randomised controlled trials are needed to find out which method is best for mothers
and babies. However, such trials are unlikely to be carried out because they would need a very large number of participants in order to
study the risk of infrequent but serious outcomes (such as rupture of the woman's uterus). Other types of studies (i.e. non-randomised
controlled trials) might be the best alternative. Future research could focus on those methods of induction that are believed to be effective
and have a low risk of serious harm. The outcomes identified as important in this review could be utilised in future studies.
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Summary of findings for the main comparison.   Vaginal PGE2 versus intravenous (IV) oxytocin
Vaginal PGE2 compared with IV oxytocin for term labour induction for women with a previous caesarean section
Patient or population: women with one previous lower segment caesarean section and requiring labour induction due to prolonged pregnancy or pre-eclampsia, singleton
in cephalic presentation, GA ≥ 37 weeks, BS < 9, no cephalopelvic disproportion anticipated
Setting: UK
Intervention: vaginal prostaglandin E2 (2.5 mg pessary)
Comparison: intravenous oxytocin
Anticipated absolute effects*
(95% CI)
Outcomes
Risk with
oxytocin
Risk with
prostaglandin
E2
Relative effect
(95% CI)
№ of participants
(studies)
Quality of the evi-
dence
(GRADE)
Comments
Vaginal delivery not achieved
within 24 hours
- - - - - Not reported
Uterine hyperstimulation
with fetal heart rate changes
- - - - - Not reported
Study populationCaesarean section
286 per 1000 191 per 1000
(63 to 580)
RR 0.67
(0.22 to 2.03)
42
(1 RCT)
⊕⊕⊝⊝
Low1
 
Study populationSerious neonatal morbidi-
ty/perinatal death
0 per 1000 0 per 1000
(0 to 0)
RR 3.00
(0.13 to 69.70)
42
(1 RCT)
⊕⊕⊝⊝
Low1
 
Study populationSerious maternal morbidity or
death
0 per 1000 0 per 1000
(0 to 0)
RR 3.00
(0.13 to 69.70)
42
(1 RCT)
⊕⊕⊝⊝
Low1
 
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
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BS: Bishop score; CI: Confidence interval; GA: gestational age; RR: Risk ratio
GRADE Working Group grades of evidence
High quality: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is sub-
stantially different
Low quality: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low quality: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
1Wide CI crossing the line of no effect, small sample size, and few events (imprecision, downgraded 2 levels).
 
 
Summary of findings 2.   Vaginal misoprostol versus intravenous (IV) oxytocin
Vaginal misoprostol compared with IV oxytocin for term labour induction for women with a previous caesarean section
Patient or population: women with a previous caesarean section
Setting: USA
Intervention: vaginal misoprostol 25 μg every 6 hours (maximum of 4 doses)
Comparison: intravenous oxytocin "per a standardised infusion protocol" see Wing 1998 (dose/regime not reported)
Anticipated absolute effects*
(95% CI)
Outcomes
Risk with
misoprostol
Risk with
oxytocin
Relative effect
(95% CI)
№ of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Vaginal delivery not achieved with-
in 24 hours
          not reported
Uterine hyperstimulation with fetal
heart rate changes
          not reported
Caesarean section           not reported
Serious neonatal morbidity or peri-
natal death
          not reported
Serious maternal morbidity or
death
          not reported
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
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CI: Confidence interval; RR: Risk ratio
GRADE Working Group grades of evidence
High quality: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is sub-
stantially different
Low quality: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low quality: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
 
 
Summary of findings 3.   Foley catheter versus intravenous (IV) oxytocin
Foley catheter compared with IV oxytocin for term labour induction for women with a previous caesarean section
Patient or population: pregnant women with a previous low transverse caesarean section, singleton live pregnancy with cephalic presentation, period of gestation > 28
weeks and BS < 5 were included in the study, with unfavourable cervix
Setting: Chandigarh, India. July 2004–November 2005
Intervention: Foley catheter balloon inflated with 30 mL of sterile saline
Comparison: intravenous oxytocin (low dose IV oxytocin, starting at 1 mU/min and increasing if contractions were not frequent after 1 hour)
Anticipated absolute effects*
(95% CI)
Outcomes
Risk with
oxytocin
Risk with Fo-
ley catheter
Relative effect
(95% CI)
№ of participants
(studies)
Quality of the evi-
dence
(GRADE)
Comments
Study populationVaginal delivery not achieved
within 24 hours
444 per 1000 653 per 1000
(396 to 1000)
RR 1.47
(0.89 to 2.44)
53
(1 RCT)
⊕⊕⊝⊝
Low1
 
Study populationUterine hyperstimulation with
fetal heart rate changes
0 per 1000 0 per 1000
(0 to 0)
RR 3.11
(0.13 to 73.09)
53
(1 RCT)
⊕⊕⊝⊝
Low1
 
Study populationCaesarean section
370 per 1000 344 per 1000
(167 to 711)
RR 0.93
(0.45 to 1.92)
53
(1 RCT)
⊕⊕⊝⊝
Low1
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Serious neonatal morbidity or
perinatal death
- - - - - Not reported
Serious maternal morbidity or
death
- - - - - Not reported
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
BS: Bishop score; CI: Confidence interval; RR: Risk ratio
GRADE Working Group grades of evidence
High quality: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is sub-
stantially different
Low quality: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low quality: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
1Wide confidence interval crossing the line of no effect, small sample size, and few events (imprecision, downgraded 2 levels).
 
 
Summary of findings 4.   Double-balloon catheter versus vaginal PGE2
Double-balloon catheter compared with vaginal PGE2 for term labour induction for women with a previous caesarean section
Patient or population: women with a previous caesarean section (subgroup of all women in the study) with intact fetal membranes, cephalic position and unfavourable
cervix, with indications for induction of labour
Setting: 7 labour wards in Denmark, December 2002-September 2005
Intervention: double-balloon catheter inserted through the cervical canal with 80 mL of saline installed stepwise in the uterine balloon and 80 mL saline in the cervicovagi-
nal balloon
Comparison: vaginal prostaglandin E2 (dinoprostone 3 mg vaginal tablet)
Anticipated absolute effects*
(95% CI)
Outcomes
Risk with
prostaglandin
E2
Risk with
double-bal-
loon catheter
Relative effect
(95% CI)
№ of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Vaginal delivery not achieved
within 24 hours
- - - - - Not reported
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Uterine hyperstimulation
with fetal heart rate changes
- - - - - Not reported
Study populationCaesarean section
571 per 1000 554 per 1000
(234 to 1000)
RR 0.97
(0.41 to 2.32)
16
(1 RCT)
⊕⊝⊝⊝
Very low1, 2
 
Serious neonatal morbidity or
perinatal death
- - - - - Not reported
Serious maternal morbidity or
death
- - - - - Not reported
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio
GRADE Working Group grades of evidence
High quality: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is sub-
stantially different
Low quality: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low quality: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
1One study with design limitations (risk of bias, downgraded 1 level).
2Wide confidence interval crossing the line of no effect, small sample size, and few events (imprecision, downgraded 2 levels).
 
 
Summary of findings 5.   Oral mifepristone versus Foley catheter
Oral mifepristone compared with Foley catheter for term labour induction for women with a previous caesarean section
Patient or population: pregnant women, 40 weeks' gestation, single cephalic presentation, 1 previous low segment caesarean section
Setting: India, 2012-2014
Intervention: oral mifepristone (400 mg) orally at 40 + 5. All women were reassessed 24 hours and 48 hours later. If BS > 6, amniotomy was performed, followed by oxytocin
infusion. If after 48 hours, BS was < 6, induction of labour was done with oxytocin infusion
Comparison: Foley catheter with 30 mL normal saline inserted at 40 + 5
Outcomes Anticipated absolute effects*
(95% CI)
Relative effect
(95% CI)
№ of participants
(studies)
Quality of the evidence
(GRADE)
Comments
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Risk with
mifepristone
Risk with Fo-
ley catheter
Vaginal delivery not achieved with-
in 24 hours
          not reported
Uterine hyperstimulation with fetal
heart rate changes
          not reported
Caesarean section           not reported
Serious neonatal morbidity or peri-
natal death
          not reported
Serious maternal morbidity or
death
          not reported
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
BS: Bishop score; CI: Confidence interval; RR: Risk ratio
GRADE Working Group grades of evidence
High quality: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is sub-
stantially different
Low quality: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low quality: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
 
 
Summary of findings 6.   Vaginal isosorbide mononitrate versus Foley catheter
Vaginal isosorbide mononitrate versus Foley catheter for term labour induction for women with a previous caesarean section
Patient or population: pregnant women with 1 previous lower segment caesarean section at 37 weeks and beyond, with a BS of ≤ 6, intact membranes, reactive non-stress
test, normal umbilical arterial Doppler indices, absence of labour and willingness of women to participate in the study
Setting: Egypt
Intervention: vaginal isosorbide mononitrate (40 mg) inserted into the posterior fornix of the vagina once
Comparison: Foley catheter No. 14-16 Fr inserted into the endocervical canal, beyond the internal os and inflated with 50-60 mL of normal saline
Outcomes Anticipated absolute effects*
(95% CI)
Relative effect
(95% CI)
№ of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Cochrane
Library
Trusted evidence.
Inform
ed decisions.
Better health.
  
Cochrane Database of System
atic Review
s
M
ethods of term
 labour induction for w
om
en w
ith a previous caesarean section (Review
)
Copyright ©
 2017 The Cochrane Collaboration. Published by John W
iley & Sons, Ltd.
10
Risk with Fo-
ley catheter
Risk with
isosorbide
mononitrate
Study populationVaginal delivery not achieved
within 24 hours
200 per 1000 526 per 1000
(264 to 1000)
RR 2.63
(1.32 to 5.21)
80
(1 RCT)
⊕⊕⊝⊝
Low1, 2
 
Uterine hyperstimulation
with fetal heart rate changes
- - - - - Not reported
Study populationCaesarean section
175 per 1000 175 per 1000
(68 to 453)
RR 1.00
(0.39 to 2.59)
80
(1 RCT)
⊕⊝⊝⊝
Very low1, 3
 
Serious neonatal morbidity or
perinatal death
- - - - - Not reported
Serious maternal morbidity or
death
- - - - - Not reported
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
BS: Bishop score; CI: Confidence interval; Fr: French; RR: Risk ratio
GRADE Working Group grades of evidence
High quality: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is sub-
stantially different
Low quality: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low quality: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
1 One study with design limitations (risk of bias, downgraded 1 level).
2 Small sample size (imprecision, downgraded 1 level).
3 Wide CI crossing the line of no effect, small sample size (imprecision, downgraded 2 levels).
 
 
Summary of findings 7.   80 mL versus 30 mL Foley catheter
80 mL Foley catheter versus 30 mL Foley catheter for term labour induction for women with a previous caesarean section
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Patient or population: pregnant women who previously had a lower segment CS and now have a singleton cephalic presentation after at least 36 completed weeks, not in
labour, with intact membranes and BS of < 6
Setting: a large tertiary centre in South India, which carries out ˜15,000 deliveries every year. October 2011-December 2013
Intervention: a 16 Fr Foley catheter was introduced into the cervix beyond the internal os and the bulb inflated with 80 mL of sterile water
Comparison: a 16 Fr Foley catheter was introduced into the cervix beyond the internal os and the bulb inflated with 30 mL of sterile water
Anticipated absolute effects*
(95% CI)
Outcomes
Risk with
30 mL Foley
catheter
Risk with
80 mL Foley
catheter
Relative effect
(95% CI)
№ of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Study populationVaginal delivery not achieved
within 24 hours
818 per 1000 859 per 1000
(745 to 982)
RR 1.05
(0.91 to 1.20)
154
(1 RCT)
⊕⊕⊕⊝
Moderate1
 
Uterine hyperstimulation
with fetal heart rate changes
- - - - - Not reported
Study populationCaesarean section
766 per 1000 805 per 1000
(682 to 950)
RR 1.05
(0.89 to 1.24)
154
(1 RCT)
⊕⊕⊕⊝
Moderate1
 
Serious neonatal morbidity or
perinatal death
- - - - - Not reported
Serious maternal morbidity or
death
- - - - - Not reported
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
BS: Bishop score; CI: Confidence interval; Fr: French; RR: Risk ratio
GRADE Working Group grades of evidence
High quality: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is sub-
stantially different
Low quality: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low quality: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
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1Small sample size (imprecision, downgraded 1 level).
 
 
Summary of findings 8.   Vaginal PGE2 pessary versus vaginal PGE2 tablet
Vaginal PGE2 pessary versus vaginal PGE2 tablet for term labour induction for women with a previous caesarean section
Patient or population: women with a previous caesarean section, a live singleton fetus (37-42 weeks of gestation) in cephalic presentation and a reactive non-stress test,
BS of ≤ 7 before onset of labour, no spontaneous contractions (< 4 contractions within 20 minutes)
Setting: large Governmental hospital, Saudi Arabia. February 2009-March 2013
Intervention: vaginal PGE2 pessary (10 mg dinoprostone sustained-release vaginal pessary)
Comparison: vaginal PGE2 tablet (1.5 mg dinoprostone vaginal tablet)
Anticipated absolute effects*
(95% CI)
Outcomes
Risk with
dinoprostone
tablet
Risk with
dinoprostone
pessary
Relative effect
(95% CI)
№ of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Vaginal delivery not
achieved within 24 hours
- - - - - Not reported
Uterine hyperstimula-
tion with fetal heart rate
changes
- - - - - Not reported
Study populationCaesarean section
330 per 1000 360 per 1000
(244 to 528)
RR 1.09
(0.74 to 1.60)
200
(1 RCT)
⊕⊝⊝⊝
Very low1, 2
 
Serious neonatal morbidity
or perinatal death
- - - - - Not reported
Serious maternal morbidity
or death
- - - - - Not reported
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
BS: Bishop score; CI: Confidence interval; RR: Risk ratio
GRADE Working Group grades of evidence
High quality: we are very confident that the true effect lies close to that of the estimate of the effect
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Moderate quality: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is sub-
stantially different
Low quality: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low quality: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect
1One study with design limitations (risk of bias, downgraded 1 level).
2Wide confidence crossing the line of no effect, small sample size (imprecision, downgraded 2 levels).
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B A C K G R O U N D
This review is an update of a review first published in 2013 (Jozwiak
2013).
Description of the condition
Worldwide, caesarean birth is common. In Australia in 2007, almost
31% of women gave birth by caesarean section (Laws 2009), with
similar figures reported from the USA (Martin 2009). While the over-
all rate of caesarean section is lower in the UK, accounting for ap-
proximately 25% of all births (NHS 2009), rates of almost 50% have
been reported in some private hospitals in Argentina, Brazil and
Chile (Belizan 1999). Women who have had a prior caesarean birth
are at increased risk of complications during a subsequent labour,
including risk of uterine rupture, presenting unique circumstances
related to the mode of birth in a subsequent pregnancy. The partic-
ular benefits and harms associated with both elective repeat cae-
sarean section and vaginal birth after caesarean section are dis-
cussed in the Cochrane Review 'Planned elective repeat caesare-
an section versus planned vaginal birth for women with a previous
caesarean section' (Dodd 2004). Current clinical practice guidelines
support vaginal birth and trial of labour among women who have
had a prior caesarean birth (ACOG 2006; RCOG 2008).
Induction of labour is a common obstetric intervention, with be-
tween 20% and 30% of births reported to occur following induction
of labour (Laws 2009; Martin 2009; Peristat 2008). The percentage
of women requiring induction of labour after a previous caesarean
birth is thought to be similar to that of other pregnant women (Lo-
catelli 2004). For women who have had a previous caesarean birth
and who require induction of labour in a subsequent pregnancy,
it is unclear whether labour should be induced, or if birth should
occur by repeat elective caesarean section. This question is con-
sidered in more detail in the Cochrane Review 'Elective repeat cae-
sarean section versus induction of labour for women with a previ-
ous caesarean birth' (Dodd 2006).
An uncommon, but potentially life-threatening complication for
both the woman and her infant associated with vaginal birth, is that
of uterine scar rupture (where the previous caesarean scar breaks
down). Uterine scar rupture is associated with a significant risk of
maternal morbidity, such as hysterectomy, genitourinary tract in-
jury, postpartum blood transfusions, and maternal death (Chuahan
2003; Zwart 2008). Increased infant morbidity and perinatal death
have been reported (Chuahan 2003). Although there is variation in
findings in different studies, in women who have had previous cae-
sarean birth, uterine rupture is reported to occur in about 8 in 1000
births with spontaneous labour, however, this risk is thought to be
almost doubled when labour is induced (NIH consensus 2010).
The focus of this current systematic review is to address the
method of induction of labour, should it be required, in women who
have had a previous caesarean section. The review draws on the
methodology of the Cochrane generic protocol related to methods
of induction of labour (Hofmeyr 2009).
Description of the intervention
Induction of labour is carried out when the risks of continuing the
pregnancy outweigh the benefits. Common indications for labour
induction include post-term pregnancy, prelabour rupture of mem-
branes, intrauterine growth restriction of the fetus, maternal hy-
pertensive disorders, and other maternal conditions. Many differ-
ent methods are available for labour induction, including pharma-
cological methods (mainly prostaglandin analogues and oxytocin),
and mechanical methods, such as Foley catheters.
How the intervention might work
Prospective and retrospective cohort studies have shown an in-
creased risk of uterine rupture in women who have had a pri-
or caesarean birth following induction of labour, especially when
prostaglandin preparations are used for cervical ripening (Landon
2004; Lydon-Rochelle 2001; Smith 2004). The risk of uterine rupture
following mechanical dilation for ripening of the cervix is reported
to be lower than with prostaglandins (Bujold 2004; Landon 2004;
Ravasia 2000), approximating the risk after spontaneous onset of
labour.
The observed increase in risk of uterine rupture following
prostaglandin administration may reflect changes that are induced
in the connective tissue of the uterine scar, thereby, weakening
it. Equally, it could be reflective of the woman’s cervix being ‘un-
favourable’ for labour (Bujold 2004; Kayani 2005), which in turn has
been recognised to be associated with adverse maternal and infant
outcomes following the trial of labour (Landon 2005).
The use of oxytocin to induce labour in women who have had a prior
caesarean birth is also associated with an increased risk of uterine
rupture (36/10,000 women without the use of oxytocin compared
with 87/10,000 women following oxytocin use) (Landon 2005).
Clinical practice guidelines vary worldwide in relation to induction
of labour for women who have had a previous caesarean section.
The Society of Obstetricians and Gynaecologists of Canada clini-
cal practice guidelines state that prostaglandins E2 (PGE2) should
only be used in exceptional circumstances, and after appropriate
counselling on the risk of uterine rupture, recommending that a Fo-
ley catheter be used in these women (SOGC 2005). The UK Nation-
al Institute for Clinical Excellence (NICE) guidelines do not make
any explicit recommendations, but do not discourage the use of
prostaglandin (RCOG 2008). In contrast, practice guidelines issued
by the American College of Obstetricians and Gynaecologists state
that the use of prostaglandins for cervical ripening or induction of
labour in most women who have had a previous caesarean section
should be discouraged (ACOG 2006).
Why it is important to do this review
Cohort studies suggest that for women who have had a previous
caesarean birth and require induction of labour in a subsequent
pregnancy, there are potential benefits and harms associated with
the induction of labour. These benefits and harms may vary consid-
erably with the method used to induce labour.
O B J E C T I V E S
To assess the benefits and harms associated with different meth-
ods used to induce labour in women who have had a previous cae-
sarean birth and require induction of labour in a subsequent preg-
nancy.
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M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised controlled trials (with reported data for women
and infants) comparing any method of term cervical ripening or
labour induction, with placebo/no treatment or other methods,
not including the comparison of induction of labour versus expec-
tant management. Quasi-randomised controlled trials, cluster-ran-
domised trials, and those presented only as an abstract were eligi-
ble for inclusion. Cross-over trials are not relevant to this interven-
tion and were not eligible for inclusion.
Types of participants
Pregnant women with a live fetus, who have had a previous cae-
sarean section, requiring induction of labour in the third trimester
of pregnancy.
Types of interventions
All methods of cervical ripening or labour induction including:
prostaglandin medication (including oral or vaginal PGE2 and
misoprostol); mifepristone; mechanical methods (including Fo-
ley catheters and double-balloon catheters); oxytocin, or placebo
compared with placebo or any other method were included.
Types of outcome measures
Clinically relevant outcomes for trials of methods of cervical ripen-
ing/labour induction have been prespecified and published in the
Cochrane generic protocol relating to induction of labour (Hofmeyr
2009).
Primary outcomes
1. Vaginal delivery not achieved within 24 hours (or period specified
by trial authors)
2. Uterine hyperstimulation with fetal heart rate (FHR) changes
3. Caesarean section
4. Serious neonatal morbidity or perinatal death (e.g. seizures, birth
asphyxia defined by trialists, neonatal encephalopathy, disability
in childhood)
5. Serious maternal morbidity or death (e.g. uterine rupture, admis-
sion to intensive care unit, septicaemia)
Secondary outcomes
Measures of e=ectiveness
6. Cervix unfavourable/unchanged after 12 to 24 hours
7. Oxytocin augmentation
Complications
8. Uterine hyperstimulation without FHR changes
9. Uterine rupture
10. Epidural analgesia
11. Instrumental vaginal delivery
12. Meconium-stained liquor
13. Apgar score less than 7 at five minutes
14. Neonatal intensive care unit admission
15. Neonatal encephalopathy
16. Perinatal death
17. Disability in childhood
18. Neonatal infection
19. Neonatal antibiotics
20. Maternal side-effects (all)
21. Maternal nausea
22. Maternal vomiting
23. Maternal diarrhoea
24. Other maternal side-effects
25. Postpartum haemorrhage
26. Chorioamnionitis
27. Endometritis
28. Maternal antibiotics
29. Serious maternal complications (e.g. intensive care unit admis-
sion, septicaemia but excluding uterine rupture)
30. Maternal death
Measures of satisfaction
31. Woman not satisfied
32. Caregiver not satisfied
'Uterine rupture' includes all clinically significant ruptures of un-
scarred or scarred uteri. Trivial scar dehiscence noted incidentally
at the time of surgery was excluded.
In the reviews, we use the term 'uterine hyperstimulation without
FHR changes' to include uterine tachysystole (more than five con-
tractions per 10 minutes for at least 20 minutes) and uterine hyper-
systole/hypertonus (a contraction lasting at least two minutes) and
'uterine hyperstimulation with FHR changes' to denote uterine hy-
perstimulation syndrome (tachysystole or hypersystole with FHR
changes such as persistent decelerations, tachycardia or decreased
short-term variability).
Outcomes are included in the analysis if data are available accord-
ing to treatment allocation and reasonable measures were taken to
minimise observer bias. While all the above outcomes were sought,
only outcomes with available data appear in the analysis tables.
Data not pre-stated were extracted and reported as not pre-speci-
fied.
Search methods for identification of studies
The following methods section of this review is based on a standard
template used by Cochrane Pregnancy and Childbirth.
Electronic searches
We searched Cochrane Pregnancy and Childbirth’s Trials Register
by contacting their Information Specialist (31 August 2016).
The Register is a database containing over 23,000 reports of con-
trolled trials in the field of pregnancy and childbirth. For full search
methods used to populate Pregnancy and Childbirth’s Trials Regis-
ter including the detailed search strategies for CENTRAL, MEDLINE,
Embase and CINAHL; the list of handsearched journals and confer-
ence proceedings, and the list of journals reviewed via the current
awareness service, please follow this link to the editorial informa-
tion about the Cochrane Pregnancy and Childbirth in the Cochrane
Library and select the ‘Specialized Register ’ section from the op-
tions on the leN side of the screen.
Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is
maintained by their Information Specialist and contains trials iden-
tified from:
Methods of term labour induction for women with a previous caesarean section (Review)
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1. monthly searches of the Cochrane Central Register of Controlled
Trials (CENTRAL);
2. weekly searches of MEDLINE (Ovid);
3. weekly searches of Embase (Ovid);
4. monthly searches of CINAHL (EBSCO);
5. handsearches of 30 journals and the proceedings of major con-
ferences;
6. weekly current awareness alerts for a further 44 journals plus
monthly BioMed Central email alerts.
Search results are screened by two people and the full text of all
relevant trial reports identified through the searching activities de-
scribed above is reviewed. Based on the intervention described,
each trial report is assigned a number that corresponds to a spe-
cific Pregnancy and Childbirth review topic (or topics), and is then
added to the Register. The Information Specialist searches the Reg-
ister for each review using this topic number rather than keywords.
This results in a more specific search set which has been fully ac-
counted for in the relevant review sections (Included studies; Ex-
cluded studies; Ongoing studies).
Searching other resources
We searched the reference lists of retrieved studies.
We did not apply any language or date restrictions.
Data collection and analysis
For methods used in the previous version of this review, see
Jozwiak 2013.
For this update, we used the following methods for assessing the
12 reports that were identified as a result of the updated search.
The following methods section of this review is based on a standard
template used by Cochrane Pregnancy and Childbirth.
Selection of studies
Two review authors independently assessed for inclusion all the
potential studies identified as a result of the search strategy. We
resolved any disagreement through discussion or, if required, we
consulted the third review author.
Data extraction and management
We designed a form to extract data. For eligible studies, two re-
view authors extracted the data using the agreed form. We re-
solved discrepancies through discussion or, if required, we consult-
ed the third review author. Data were entered into Review Manager
5 (RevMan 5) software (RevMan 2014) and checked for accuracy.
When information regarding any of the above was unclear, we
planned to contact authors of the original reports to provide further
details.
Assessment of risk of bias in included studies
Two review authors independently assessed risk of bias for each
study using the criteria outlined in the Cochrane Handbook for Sys-
tematic Reviews of Interventions (Higgins 2011a). Any disagreement
was resolved by discussion or by involving a third assessor.
1. Random sequence generation (checking for possible selection
bias)
We described for each included study the method used to generate
the allocation sequence in sufficient detail to allow an assessment
of whether it should produce comparable groups.
We assessed the method as:
• low risk of bias (any truly random process, e.g. random number
table; computer random-number generator);• high risk of bias (any non-random process, e.g. odd or even date
of birth; hospital or clinic record number);• unclear risk of bias.
2. Allocation concealment (checking for possible selection bias)
We described for each included study the method used to con-
ceal allocation to interventions prior to assignment and assessed
whether intervention allocation could have been foreseen in ad-
vance of, or during recruitment, or changed after assignment.
We assessed the methods as:
• low risk of bias (e.g. telephone or central randomisation; con-
secutively-numbered, sealed, opaque envelopes);• high risk of bias (open random allocation; unsealed or non-
opaque envelopes, alternation; date of birth);• unclear risk of bias.
3.1. Blinding of participants and personnel (checking for
possible performance bias)
We described for each included study the methods used, if any, to
blind study participants and personnel from knowledge of which
intervention a participant received. We considered that studies
were at low risk of bias if they were blinded, or if we judged that
the lack of blinding unlikely to affect results. We assessed blinding
separately for different outcomes or classes of outcomes.
We assessed the methods as:
• low, high or unclear risk of bias for participants;• low, high or unclear risk of bias for personnel.
3.2. Blinding of outcome assessment (checking for possible
detection bias)
We described for each included study the methods used, if any, to
blind outcome assessors from knowledge of which intervention a
participant received. We assessed blinding separately for different
outcomes or classes of outcomes.
We assessed methods used to blind outcome assessment as:
• low, high or unclear risk of bias.
4. Incomplete outcome data (checking for possible attrition bias
due to the amount, nature and handling of incomplete outcome
data)
We described for each included study, and for each outcome or
class of outcomes, the completeness of data including attrition and
exclusions from the analysis. We stated whether attrition and ex-
clusions were reported and the numbers included in the analysis at
each stage (compared with the total randomised participants), rea-
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sons for attrition or exclusion where reported, and whether miss-
ing data were balanced across groups or were related to outcomes.
Where sufficient information was reported, or could be supplied
by the trial authors, we planned to re-include missing data in the
analyses that we undertook.
We assessed methods as:
• low risk of bias (e.g. no missing outcome data; missing outcome
data balanced across groups);• high risk of bias (e.g. numbers or reasons for missing data imbal-
anced across groups; ‘as-treated’ analysis done with substan-
tial departure of intervention received from that assigned at ran-
domisation);• unclear risk of bias.
5. Selective reporting (checking for reporting bias)
We described for each included study how we investigated the pos-
sibility of selective outcome reporting bias and what we found.
We assessed the methods as:
• low risk of bias (where it is clear that all of the study’s pre-spec-
ified outcomes and all expected outcomes of interest to the re-
view have been reported);• high risk of bias (where not all the study’s pre-specified out-
comes have been reported; one or more reported primary out-
comes were not pre-specified; outcomes of interest are report-
ed incompletely and so cannot be used; study fails to include re-
sults of a key outcome that would have been expected to have
been reported);• unclear risk of bias.
6. Other bias (checking for bias due to problems not covered by
(1) to (5) above)
We described for each included study any important concerns we
had about other possible sources of bias.
7. Overall risk of bias
We made explicit judgements about whether studies were at high
risk of bias, according to the criteria given in the Cochrane Hand-
book for Systematic Reviews of interventions (Higgins 2011a). With
reference to (1) to (6) above, we planned to assess the likely mag-
nitude and direction of the bias and whether we considered it
was likely to impact on the findings. In future updates, we will ex-
plore the impact of the level of bias through undertaking sensitivity
analyses - see Sensitivity analysis.
Assessing the quality of the evidence using GRADE
For this update we have assessed the quality of the evidence using
the GRADE approach as outlined in the GRADE handbook in order to
assess the quality of the body of evidence relating to the following
outcomes for the main comparisons.
1. Vaginal delivery not achieved within 24 hours (or period speci-
fied by trial authors)
2. Uterine hyperstimulation with fetal heart rate changes
3. Caesarean section
4. Serious neonatal morbidity or perinatal death (e.g. seizures,
birth asphyxia defined by trialists, neonatal encephalopathy,
disability in childhood)
5. Serious maternal morbidity or death (e.g. uterine rupture, ad-
mission to intensive care unit, septicaemia)
We used GRADEpro Guideline Development Tool (GRADEpro GDT)
to import data from RevMan 5 (RevMan 2014) in order to create
'Summary of findings' tables. We produced a summary of the in-
tervention effect and a measure of quality for each of the above
outcomes using the GRADE approach. The GRADE approach uses
five considerations (study limitations, consistency of effect, impre-
cision, indirectness and publication bias) to assess the quality of
the body of evidence for each outcome. The evidence can be down-
graded from 'high quality' by one level for serious (or by two levels
for very serious) limitations, depending on assessments for risk of
bias, indirectness of evidence, serious inconsistency, imprecision
of effect estimates or potential publication bias.
Measures of treatment e=ect
Dichotomous data
For dichotomous data, we presented results as summary risk ratio
with 95% confidence intervals.
Continuous data
We used the mean difference if outcomes were measured in the
same way between trials. We used the standardised mean differ-
ence to combine trials that measured the same outcome, but used
different methods.
Unit of analysis issues
Cluster-randomised trials
Our searches did not identify any cluster-randomised trials for in-
clusion in the analyses. In future updates, if we identify any clus-
ter-randomised controlled trials we will include them in our analy-
ses along with the individually randomised trials. We will adjust
their sample sizes using the methods described in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011b)
using an estimate of the intracluster correlation co-efficient (ICC)
derived from the trial (if possible), from a similar trial or from a
study of a similar population. If we use ICCs from other sources, we
will report this and conduct sensitivity analyses to investigate the
effect of variation in the ICC. We will consider it reasonable to com-
bine the results from both if there is little heterogeneity between
the study designs and the interaction between the effect of inter-
vention and the choice of randomisation unit is considered to be
unlikely.
Cross-over trials
Cross-over trials are inappropriate for this intervention.
Multi-armed trials
We identified one multi-arm trial, however only two arms were re-
ported in the study publication. We contacted the trial authors to
request data on the other arms but did not receive a reply. If we
had received these data, we would have combined all relevant ex-
perimental intervention groups of the study into a single group and
all relevant control intervention groups into a single control group
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when we analysed the data. If we had considered one of the arms
irrelevant, we would have excluded it from analysis.
Dealing with missing data
For included studies, we noted levels of attrition. In future updates,
if we include more eligible studies, we will explore the impact of
including studies with high levels of missing data in the overall as-
sessment of treatment effect using sensitivity analysis.
For all outcomes, we carried out analyses, as far as possible, on an
intention-to-treat basis, that is, we attempted to include all partic-
ipants randomised to each group in the analyses. The denominator
for each outcome in each trial was the number randomised minus
any participants whose outcomes were known to be missing.
Assessment of heterogeneity
We did not combine data from the included studies. In future up-
dates we will assess statistical heterogeneity in each meta-analy-
sis using the Tau2, I2 (Higgins 2003) and Chi2 statistics (Deeks 2011).
We will regard heterogeneity as substantial if I2 is greater than 30%
and either Tau2 is greater than zero, or there is a low P value (less
than 0.10) in the Chi2 test for heterogeneity. If we identify substan-
tial heterogeneity (above 30%), we will explore it by pre-specified
subgroup analysis.
Assessment of reporting biases
In future updates, if there are 10 or more studies in the meta-analy-
sis we will investigate reporting biases (such as publication bias)
using funnel plots. We will assess funnel plot asymmetry visually.
If asymmetry is suggested by a visual assessment, we will perform
exploratory analyses to investigate it.
Data synthesis
Meta-analysis was not possible because the studies compared dif-
ferent methods of labour induction. In future updates we will carry
out statistical analysis using RevMan 5 software (RevMan 2014). We
will use fixed-effect meta-analysis for combining data where it was
reasonable to assume that studies were estimating the same un-
derlying treatment effect: that is, where trials were examining the
same intervention, and the trials’ populations and methods were
judged sufficiently similar.
If there is clinical heterogeneity sufficient to expect that the un-
derlying treatment effects differed between trials, or if substantial
statistical heterogeneity is detected, we will use random-effects
meta-analysis to produce an overall summary if an average treat-
ment effect across trials is considered clinically meaningful. The
random-effects summary will be treated as the average range of
possible treatment effects and we will discuss the clinical implica-
tions of treatment effects differing between trials. If the average
treatment effect is not clinically meaningful, we will not combine
trials. If we use random-effects analyses, we will present the results
as the average treatment effect with 95% confidence intervals, and
the estimates of Tau2 and I2.
Subgroup analysis and investigation of heterogeneity
In future updates, if we identify substantial heterogeneity, we will
investigate it using subgroup analyses and sensitivity analyses. We
will considered whether an overall summary is meaningful, and if it
is, we will use a random-effects analysis to produce it.
We plan to carry out the following subgroup analyses:
1. previous vaginal birth (yes versus no);
2. number of previous caesarean births (one versus two versus
three or more);
3. indication for previous caesarean birth(s) (failure to progress
versus fetal distress versus other);
4. indication for labour induction (hypertensive disorders versus
post-term pregnancy versus intrauterine growth restriction ver-
sus maternal disease versus other indication);
5. favourability of the cervix (favourable versus unfavourable);
6. status of membranes (ruptured versus unruptured);
7. gestational age (37 to 40 weeks versus 40 to 41 weeks versus
more than 41 weeks).
We will restrict planned subgroup analysis to the primary out-
comes.
We will assess subgroup differences by interaction tests available
within RevMan 5 (RevMan 2014). We will report the results of sub-
group analyses quoting the Chi2 statistic and P value, and the inter-
action test I2 value.
Sensitivity analysis
In future updates, we will carry out sensitivity analyses, where ap-
propriate, to explore the effect of trial quality assessed by conceal-
ment of allocation, high attrition rates, or both, with poor-qual-
ity studies being excluded from the analyses in order to assess
whether this makes any difference to the overall result.
R E S U L T S
Description of studies
Results of the search
The updated search of Cochrane Pregnancy and Childbirth's Trials
Register retrieved 12 reports (see Figure 1). We included six new
studies (10 reports) (Hassan 2014; Lokkegaard 2015; Manish 2016;
Meetei 2015; Rezk 2014; Sharma 2015). One new study was exclud-
ed (Ramya 2015) and one study is ongoing (NCT02196103).
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Figure 1.   Study flow diagram
 
Included studies
See Characteristics of included studies.
Altogether we included eight studies in the review (Hassan 2014;
Lokkegaard 2015; Manish 2016; Meetei 2015; Rezk 2014; Sharma
2015; Taylor 1993; Wing 1998). A subset of the women who partici-
pated in Lokkegaard 2015 had a prior caesarean section, and it was
only this subset of results that we included in our review. Only data
for women who were 37 weeks' gestation or more in Meetei 2015
were included in this review (unpublished data supplied by the trial
author).
Design
Seven of the included studies were two-arm randomised controlled
trials (Hassan 2014; Lokkegaard 2015; Manish 2016; Meetei 2015;
Rezk 2014; Taylor 1993; Wing 1998), one was a four-arm randomised
controlled trial however only two arms were reported in the pub-
lications (Sharma 2015). Trials compared different methods of
labour induction.
Sample sizes
The studies range in size from 26 women (Lokkegaard 2015) to 200
women (Hassan 2014). The total number of women contributing
data to the review is 707.
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Setting
Three studies took place in India (Manish 2016; Meetei 2015; Shar-
ma 2015), one in Saudi Arabia (Hassan 2014), one in Denmark
(Lokkegaard 2015), one in Egypt (Rezk 2014), one in the UK (Taylor
1993), and one in the USA (Wing 1998).
Participants
All participants were women with a prior caesarean section. In
Lokkegaard 2015 this was a subgroup within a trial of all women
undergoing induction.
All studies looked at induction at term, or approaching term. The
gestational age at which women were eligible varied: in Sharma
2015 women were 40 weeks' gestation, in Manish 2016, Rezk 2014
and Taylor 1993 they were at least 37 weeks gestational age, and
in Hassan 2014 they were 37 to 42 weeks' gestation. The inclusion
criteria in Meetei 2015 is from 28 weeks gestational age. The ges-
tational age of women who took part is not reported, although it
states that the majority of women were between 38 and 40 weeks.
In personal communication, the trial author reported that 26 out
of 30 women in the Foley catheter group, and 27 out of 30 in the
oxytocin group were 37 weeks' gestation or more, and provided da-
ta for this subgroup of women. Lokkegaard 2015 does not state a
specific gestational age among the inclusion criteria. In the whole
study the earliest gestational age was 32 + 5, however this informa-
tion is not given in the published report for the subgroup of women
with a prior caesarean. In personal communication, the trial author
reported that all women with a prior caesarean were 37 weeks' ges-
tation or more. The gestational age for included women is not stat-
ed in Wing 1998.
The indications for induction of labour varied between studies. Tay-
lor 1993 included only women with post-term pregnancy or pre-
eclampsia. Sharma 2015 included only women with a post-term
pregnancy (defined by the trialists as from 40 weeks five days). Has-
san 2014, Lokkegaard 2015, Manish 2016, Meetei 2015, Rezk 2014
and Wing 1998 used broad criteria for induction, including post-
term pregnancy, pre-eclampsia or hypertension, gestational dia-
betes mellitus, oligohydramnios and intrauterine growth restric-
tion.
Seven studies specified cephalic presentation in the inclusion cri-
teria (Hassan 2014; Lokkegaard 2015; Manish 2016; Meetei 2015;
Sharma 2015; Taylor 1993; Wing 1998). Seven studies included on-
ly women with a singleton pregnancy (Hassan 2014; Manish 2016;
Meetei 2015; Rezk 2014; Sharma 2015; Taylor 1993; Wing 1998).
Lokkegaard 2015 did not exclude multiple pregnancies, however
there were none in the subgroup of women with a previous cae-
sarean section. Six studies specified that women could participate
if they had had a previous low transverse or lower segment cae-
sarean section (Hassan 2014; Manish 2016; Meetei 2015; Rezk 2014;
Sharma 2015; Taylor 1993). Wing 1998 included women with one
prior caesarean, but found that verifying the type of incision was
"often impossible in our population", and Lokkegaard 2015 did not
report on the number or nature of prior caesarean(s).
Hassan 2014, Lokkegaard 2015, Manish 2016 and Rezk 2014 spec-
ified in their inclusion criteria that membranes had to be unrup-
tured, as did the previous trial cited by Wing 1998 as having simi-
lar inclusion and exclusion criteria to this study (Wing 1996). Meetei
2015 and Sharma 2015 excluded women with premature rupture
of membranes from their studies, and Taylor 1993 did not describe
the status of membranes for women to be included in the trial.
The inclusion criteria of studies specified Bishop scores of less than
or equal to seven (Hassan 2014), less than or equal to six (Rezk
2014), less than six (Lokkegaard 2015; Manish 2016), less than five
(Meetei 2015), less than or equal to four (Wing 1998), and modi-
fied Bishop score less than nine (Taylor 1993). Sharma 2015 did not
specify.
No information was reported on the indication for the previous
caesarean section, or whether women had had a previous vaginal
birth, in Lokkegaard 2015, Manish 2016, Meetei 2015, Rezk 2014 and
Sharma 2015. In Taylor 1993, women whose only previous pregnan-
cy was delivered by caesarean section were included, so no women
had had a prior vaginal birth. The indications for previous caesare-
an sections are listed in a table in the report. Wing 1998 required
that women had not had a vaginal birth since their caesarean sec-
tion. Some women in Manish 2016 had had more than one previ-
ous pregnancy (seven out of 70 in the 30 mL group, four out of 70
in the 80 mL group), however it does not report whether these pre-
vious births were caesarean or vaginal deliveries. Hassan 2014 re-
ports that 56 out of 100 women in the tablet group and 62 out of
100 women in the pessary group had had a prior vaginal delivery,
in addition to their previous caesarean section.
Interventions
Three studies made a comparison with oxytocin: vaginal PGE2
(Taylor 1993), vaginal misoprostol (Wing 1998), and Foley catheter
(Meetei 2015). Two additional studies made a comparison with Fo-
ley catheter: oral mifepristone (Sharma 2015), and vaginal isosor-
bide mononitrate (Rezk 2014). One study compared double-bal-
loon catheter with vaginal PGE2 (Lokkegaard 2015), one compared
30 mL Foley catheter with 80 mL Foley catheter (Manish 2016), and
one compared vaginal PGE2 tablet with vaginal PGE2 pessary (Has-
san 2014).
The dose of intravenous oxytocin was started at 1 mU/minute and
increased if contractions were not frequent after one hour in Meetei
2015, "per a standardized infusion protocol" in Wing 1998, and in
Taylor 1993, the dose was not reported. Amniotomy was done at
the start of oxytocin administration Taylor 1993 and Wing 1998, but
is not reported in Meetei 2015. PGE2 was administered as a 2.5 mg
vaginal pessary (Taylor 1993), or 3 mg vaginal tablet (Lokkegaard
2015). The dose of misoprostol was 25 μg intravaginally every six
hours to a maximum of four doses (Wing 1998). The Foley catheter
balloon was inserted to the endocervix and inflated with 30 mL of
sterile saline (Meetei 2015; Sharma 2015) or inserted into the cervix
beyond the internal os and inflated with 80 mL or 30 mL of sterile
water (Manish 2016) or 50 mL to 60 mL of normal saline (Rezk 2014).
The double-balloon catheter was inflated with 80 mL of saline in the
uterine balloon and 80 mL of saline in the cervicovaginal balloon
(Lokkegaard 2015). Women received a dose of 400 mg mifepristone
orally (Sharma 2015). Women received either 1.5 mg PGE2 (dino-
prostone) vaginal tablet into the posterior vaginal fornix for a max-
imum of three doses with six-hourly intervals, or a single dose of
PGE2 (dinoprostone) 10 mg sustained-release vaginal pessary into
the posterior vaginal fornix (Hassan 2014).
Outcomes
Three studies reported very few of our prespecified outcomes or
did not report them in a form that could be included in the review
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(Lokkegaard 2015; Sharma 2015; Wing 1998). Perinatal outcomes
were especially scarce. Wing 1998 reported only uterine rupture,
and Sharma 2015 reported oxytocin augmentation and uterine rup-
ture. Caesarean section and neonatal unit admission were the only
prespecified outcomes reported for the subgroup of women with a
previous caesarean in Lokkegaard 2015.
Five studies reported more of our prespecified outcomes (Hassan
2014; Manish 2016; Meetei 2015; Rezk 2014; Taylor 1993), including
the primary outcomes: any delivery not achieved within 24 hours
(Manish 2016; Meetei 2015; Rezk 2014), uterine hyperstimulation
with FHR changes (Meetei 2015), caesarean section (Hassan 2014;
Manish 2016; Meetei 2015; Rezk 2014; Taylor 1993), serious neona-
tal morbidity or perinatal death (Taylor 1993), and serious mater-
nal morbidity or death (Taylor 1993). In several studies (e.g. Hassan
2014; Manish 2016; Rezk 2014) the composite outcomes were not
reported, but individual elements of them were, for example, peri-
natal death, uterine rupture, and maternal admission to intensive
care unit.
Excluded studies
See Characteristics of excluded studies.
We excluded nine studies (Arraztoa 1994; Ben-Aroya 2001; Ham-
dan 2009; Lelaidier 1994; Morales 1986; Ramya 2015; Rayburn 1999;
Sciscione 2001; Spallicci 2007).
The studies by Arraztoa 1994, Morales 1986 and Rayburn 1999 com-
pared a pharmacological method of induction of labour with ongo-
ing expectant management of the pregnancy. The Ben-Aroya 2001
study did not involve a randomised comparison, while Hamdan
2009 and Ramya 2015 compared weekly membrane sweeping with
weekly vaginal examination, in women who did not require induc-
tion of labour.
The Lelaidier 1994 study compared mifepristone with placebo as a
pre-induction agent, followed by vaginal prostaglandin induction
in all women after an observation period of four days. Spallicci 2007
compared hyaluronidase with placebo in women with a prior cae-
sarean birth at term, who did not require induction of labour. Scis-
cione 2001 compared transcervical Foley catheter with misoprostol
to induce labour in women with a prior caesarean birth. However,
the trial inclusion criteria were modified to exclude women with a
prior caesarean birth, following the occurrence of a uterine rupture
in the misoprostol group.
Risk of bias in included studies
Assessment of the methodological quality of the included studies
was based on risk of bias in relation to selection bias (method of
randomisation and allocation concealment), performance bias, de-
tection bias, attrition bias (loss of participants from the analyses)
and reporting bias. Summaries of 'Risk of bias' assessments for
each study, and for included trials overall, are set out in Figure 2
and Figure 3.
 
Figure 2.   Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies
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Figure 3.   Risk of bias summary: review authors' judgements about each risk of bias item for each included study
 
Allocation (selection bias)
Generation of the randomisation sequence
Three studies reported using a computer-generated random se-
quence (Lokkegaard 2015; Manish 2016; Rezk 2014) and one used
Tippets random number table (Meetei 2015), which we judged were
at low risk of bias. The method of generating the randomisation se-
quence was not described in two studies (Hassan 2014; Wing 1998),
which we judged to be unclear risk of bias. Sharma 2015 reported an
intention to use computer-generated randomisation in the study
Methods of term labour induction for women with a previous caesarean section (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
22
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
protocol, but this was not reported in the study report. We contact-
ed the study author to clarify the method, but no response has been
received, so their method was judged to be unclear risk of bias. Tay-
lor 1993 described using "predetermined code envelope" which we
also judged to be at unclear risk of bias.
Allocation concealment
In three of the studies, the method for concealing group allocation
at the point of randomisation was at low risk of bias: randomised by
a central telephone automatic voice-response system (Lokkegaard
2015), and sealed, opaque envelopes (Manish 2016; Taylor 1993).
The method for concealing group allocation was not described in
Hassan 2014, Meetei 2015, Rezk 2014 or Wing 1998, which we judged
to be at unclear risk of bias. Sharma 2015 reported an intention
to use "sequentially numbered, sealed, opaque envelopes" in the
study protocol, but this was not described in the study report, and
enquiries to clarify the method were not answered, so we decided
it was at unclear risk of bias.
Blinding (performance bias and detection bias)
Manish 2016 is the only study that reported any attempt to blind
women or health professionals to group allocation. In this study,
the decision to perform caesarean section was leN to the discretion
of an obstetrician who was unaware of group allocation. Women
were unlikely to be aware of how much sterile water was in the Fo-
ley catheter, despite the personnel responsible for inserting and re-
moving the catheter knowing. Therefore blinding was not perfect,
but the bias was minimised and we judged it to be low risk of bias.
No other studies were blinded (Hassan 2014; Lokkegaard 2015;
Meetei 2015; Rezk 2014; Sharma 2015; Taylor 1993; Wing 1998). It
was not feasible to blind women or health professionals to most of
these comparisons. This may have had an effect on other treatment
decisions. All included studies have consequently been assessed as
high risk of bias due to lack of blinding. It might have been possible
to blind outcome assessors, but this was not described in any stud-
ies, so they were all judged to be at unclear risk of bias.
Incomplete outcome data (attrition bias)
Five studies were judged to be at low risk of attrition bias. All
women appear to be accounted for and there is no mention of
women dropping out of the study in Hassan 2014, Manish 2016,
Meetei 2015, Rezk 2014 and Taylor 1993.
Two studies had unclear risk of attrition bias. In Sharma 2015, all
women recruited appear to be accounted for in the results. Howev-
er, the omission of two arms of the study may suggest bias. There is
insufficient information in Wing 1998 to judge whether all women
were accounted for.
One study was at high risk of bias. Women in Lokkegaard 2015 who
went into spontaneous labour before induction, who were not in
labour after 48 hours, or who had been coded as "VBAC" (vaginal
birth after caesarean section) in error were classed as ‘failure’ and
excluded from the results. There were 13 women randomised to
each group, however results for only 10 are reported in the publica-
tion, and in correspondence from the study author additional 'fail-
ures' were identified. In the Minprostin group, two women began
labour before induction, three were not in labour after 48 hours,
and one was wrongly coded as VBAC. In the balloon group, three
began labour before induction, one was not VBAC and 0 were not
in labour after 48 hours. Unfortunately, despite additional informa-
tion from the study authors, there were still missing data on out-
comes, and we were unable to add the excluded women in an in-
tention-to-treat analysis.
Selective reporting (reporting bias)
Two studies were judged to be at high risk of reporting bias. The
protocol for Sharma 2015 describes a four-arm study, but only two
arms were reported in the publication. The abstracts from which it
was assessed do not report any prespecified neonatal outcomes,
and report only two arms of the four comparison groups set out in
the protocol. No response was received from the authors when ad-
ditional details were requested. In Wing 1998, uterine rupture is the
only outcome reported. It is likely that other outcomes were pre-
specified and these are not reported.
Four studies were at unclear risk of reporting bias: Meetei 2015,
Rezk 2014 and Taylor 1993 were assessed from published reports,
without protocols available. It is unclear whether all prespecified
outcomes were reported in these studies. Several secondary out-
comes prespecified in the protocol for Manish 2016 were not report-
ed in the published study report. In Lokkegaard 2015 the subset of
participants with a previous VBAC were not the primary focus of this
study, so few outcomes are reported for these women.
One study was at low risk of reporting bias: Hassan 2014 was as-
sessed from a published report with no protocol available, howev-
er outcomes were comprehensively reported.
Other potential sources of bias
Five studies were at low risk: the groups were comparable at base-
line, and no other potential sources of bias were identified (Hassan
2014; Manish 2016; Meetei 2015; Rezk 2014; Taylor 1993).
Three studies were considered to be at high risk of other bias: the
inconsistencies between the study protocol and published report
for Sharma 2015 suggest that this study is at high risk of other bias.
In Lokkegaard 2015 the primary endpoints of the full study are re-
ported by both intention-to-treat and per-protocol analyses, indi-
cating that a large proportion of women did not receive the allo-
cated treatment. Wing 1998 was stopped prematurely due to safety
concerns.
E=ects of interventions
See: Summary of findings for the main comparison Vaginal PGE2
versus intravenous (IV) oxytocin; Summary of findings 2 Vaginal
misoprostol versus intravenous (IV) oxytocin; Summary of find-
ings 3 Foley catheter versus intravenous (IV) oxytocin; Summary of
findings 4 Double-balloon catheter versus vaginal PGE2; Summa-
ry of findings 5 Oral mifepristone versus Foley catheter; Summary
of findings 6 Vaginal isosorbide mononitrate versus Foley catheter;
Summary of findings 7 80 mL versus 30 mL Foley catheter; Sum-
mary of findings 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet
We did not combine data from the six included studies because
they used different methods of induction of labour, so we did not
consider meta-analysis appropriate.
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1. Vaginal PGE2 inserts versus intravenous oxytocin
A single study involving 42 women compared vaginal PGE2 with in-
travenous oxytocin for induction of labour (Taylor 1993). See Sum-
mary of findings for the main comparison.
Primary outcomes
There were no differences identified between the two treatment
groups for caesarean section (risk ratio (RR) 0.67, 95% confidence
interval (CI) 0.22 to 2.03, one study, 42 women, evidence graded
low, Analysis 1.1). There was only one event for serious neonatal
morbidity or perinatal death and serious maternal morbidity
or death, so the analysis of differences between groups was not
meaningful (one study, 42 women, evidence graded low, Analysis
1.2; one study, 42 women, evidence graded low, Analysis 1.3).
The study did not report the following primary/GRADE outcomes:
vaginal delivery not achieved within 24 hours, anduterine hy-
perstimulation with fetal heart rate (FHR) changes.
Secondary outcomes
One woman was identified as having a uterine rupture follow-
ing prostaglandin administration, so the analysis is not meaning-
ful (one study, 42 women, Analysis 1.4). There were no differences
identified in the secondary maternal or infant outcomes, including
use of epidural analgesia (RR 1.42, 95% CI 0.93 to 2.17, one study,
42 women, Analysis 1.5), instrumental vaginal delivery (RR 1.25,
95% CI 0.39 to 4.02, one study, 42 women, Analysis 1.6), or Apgar
score of less than seven at five minutes (no events, one study, 42
infants, Analysis 1.7).
The study did not report the following secondary outcomes:
cervix unfavourable/unchanged after 12 to 24 hours, oxytocin
augmentation, uterine hyperstimulation without FHR changes,
meconium-stained liquor, neonatal intensive care unit admission,
neonatal encephalopathy, perinatal death, disability in childhood,
neonatal infection, neonatal antibiotics, maternal side-effects (all),
maternal nausea, maternal vomiting, maternal diarrhoea, other
maternal side-effects, postpartum haemorrhage, chorioamnioni-
tis, endometritis, maternal antibiotics, serious maternal complica-
tions (e.g. intensive care unit admission, septicaemia but excluding
uterine rupture), maternal death, woman not satisfied, and care-
giver not satisfied.
2. Vaginal misoprostol versus intravenous oxytocin
There was one study comparing vaginal misoprostol and intra-
venous oxytocin included in the review (Wing 1998). No GRADE out-
comes were reported. See Summary of findings 2.
Primary outcomes
This trial was stopped following recruitment and randomisation
of 38 women (17 women misoprostol group; 21 women oxytocin
group) and no primary outcomes or GRADE outcomes were report-
ed (vaginal delivery not achieved within 24 hours, uterine hy-
perstimulation with FHR changes, caesarean section, serious
neonatal morbidity or perinatal death, and serious maternal
morbidity or death).
Secondary outcomes
The only outcome reported was uterine rupture, which occurred
in one woman in the misoprostol group (RR 3.67, 95% CI 0.16 to
84.66, one study, 38 women, Analysis 2.1). One woman in the miso-
prostol group also experienced uterine dehiscence.
The study did not report the following secondary outcomes: cervix
unfavourable/unchanged after 12 to 24 hours, oxytocin augmenta-
tion, uterine hyperstimulation without FHR changes, epidural anal-
gesia, instrumental vaginal delivery, meconium-stained liquor, Ap-
gar score less than seven at five minutes, neonatal intensive care
unit admission, neonatal encephalopathy, perinatal death, disabil-
ity in childhood, neonatal infection, neonatal antibiotics, maternal
side-effects (all), maternal nausea, maternal vomiting, maternal
diarrhoea, other maternal side-effects, postpartum haemorrhage,
chorioamnionitis, endometritis, maternal antibiotics, serious ma-
ternal complications (e.g. intensive care unit admission, septi-
caemia but excluding uterine rupture), maternal death, woman not
satisfied, and caregiver not satisfied.
3. Foley catheter versus intravenous oxytocin
One study comparing Foley catheter with intravenous oxytocin was
included (Meetei 2015). The study author supplied unpublished da-
ta for the women who were 37 weeks' gestation or more (53 of the
60 women who participated). See Summary of findings 3.
Primary outcomes
There was no difference between oxytocin and Foley catheter in the
number of women who delivered within 24 hours (RR 1.47, 95%
CI 0.89 to 2.44, one study, 53 women, evidence graded low, Analysis
3.1), uterine hyperstimulation with FHR changes (RR 3.11, 95% CI
0.13 to 73.09, one study, 53 women, evidence graded low, Analysis
3.2), or the number of women requiring a caesarean section (RR
0.93, 95% CI 0.45 to 1.92, one study, 53 women, evidence graded
low, Analysis 3.3).
The study did not report the following primary/GRADE composite
outcomes: serious neonatal morbidity or perinatal death, and
serious maternal morbidity or death.
Secondary outcomes
There was no difference between the groups in the number of
women requiring oxytocin augmentation (RR 1.04, 95% CI 0.81
to 1.32, one study, 53 women, Analysis 3.4), uterine rupture (no
events, one study, 53 women, Analysis 3.5), instrumental vaginal
delivery (RR 7.26, 95% CI 0.39 to 134.01, one study, 53 women,
Analysis 3.6), postpartum haemorrhage (RR 3.11, 95% CI 0.13 to
73.09, one study, 53 women, Analysis 3.7) and chorioamnionitis
(not estimable, one study, 53 women, Analysis 3.8). However the
number of events for each of these outcomes was very low and the
study did not include enough women to show differences between
the groups. Two women in the oxytocin group had scar dehiscence,
while none in the Foley catheter group did.
The study did not report the following secondary outcomes: cervix
unfavourable/unchanged after 12 to 24 hours, uterine hyperstimu-
lation without FHR changes, epidural analgesia, meconium-stained
liquor, Apgar score less than seven at five minutes, neonatal in-
tensive care unit admission, neonatal encephalopathy, perinatal
death, disability in childhood, neonatal infection, neonatal antibi-
otics, maternal side-effects (all), maternal nausea, maternal vom-
iting, maternal diarrhoea, other maternal side-effects, endometri-
tis, maternal antibiotics, serious maternal complications (e.g. in-
tensive care unit admission, septicaemia but excluding uterine rup-
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ture), maternal death, woman not satisfied, and caregiver not sat-
isfied.
4. Double-balloon catheter versus vaginal PGE2
One study compared double-balloon catheter with vaginal PGE2
(Lokkegaard 2015). Data from the subgroup of women who had
had a previous caesarean section were included in this review. See
Summary of findings 4.
Primary outcomes
There was no difference between the groups for caesarean section
(RR 0.97, 95% CI 0.41 to 2.32, one study, 16 women, evidence graded
very low, Analysis 4.1).
The study did not report the following primary/GRADE outcomes:
vaginal delivery not achieved within 24 hours, uterine hyper-
stimulation with FHR changes, serious neonatal morbidity or
perinatal death, and serious maternal morbidity or death.
Failed induction was reported (three out of 12 women in the dou-
ble-balloon catheter group, and five out of 12 women in the dino-
prostone group), however we did not included this outcome in this
review as it included women who started labour before induction
began and women who had not delivered 48 hours after induction
began.
Secondary outcomes
No babies in this subgroup of the study were admitted to neonatal
unit (not estimable, one study, 20 infants, Analysis 4.2).
The study did not report the following secondary outcomes: cervix
unfavourable/unchanged after 12 to 24 hours, oxytocin augmenta-
tion, uterine hyperstimulation without FHR changes, uterine rup-
ture, epidural analgesia, instrumental vaginal delivery, meconi-
um-stained liquor, Apgar score less than seven at five minutes,
neonatal encephalopathy, perinatal death, disability in childhood,
neonatal infection, neonatal antibiotics, maternal side-effects (all),
maternal nausea, maternal vomiting, maternal diarrhoea, other
maternal side-effects, postpartum haemorrhage, chorioamnioni-
tis, endometritis, maternal antibiotics, serious maternal complica-
tions (e.g. intensive care unit admission, septicaemia but excluding
uterine rupture), maternal death, woman not satisfied, and care-
giver not satisfied.
5. Oral mifepristone versus Foley catheter
One study compared oral mifepristone versus Foley catheter (Shar-
ma 2015). No GRADE outcomes were reported. See Summary of
findings 5.
Primary outcomes
The study did not report any of the primary/GRADE outcomes: vagi-
nal delivery not achieved within 24 hours, uterine hyperstim-
ulation with FHR changes, caesarean section, serious neonatal
morbidity or perinatal death, and serious maternal morbidity
or death.
Secondary outcomes
More women who were induced with Foley catheter than mifepris-
tone required further oxytocin augmentation (RR 0.54, 95% CI 0.38
to 0.76, one study, 107 women, Analysis 5.1). The number of women
who had a uterine rupture was slightly lower with mifepristone
(three out of 57, compared with nine out of 50), however this does
not show a clear difference between groups (RR 0.29, 95% CI 0.08
to 1.02, one study, 107 women, Analysis 5.2).
The study did not report the following secondary outcomes: cervix
unfavourable/unchanged after 12 to 24 hours, uterine hyperstimu-
lation without FHR changes, epidural analgesia, instrumental vagi-
nal delivery, meconium-stained liquor, Apgar score less than seven
at five minutes, neonatal intensive care unit admission, neonatal
encephalopathy, perinatal death, disability in childhood, neonatal
infection, neonatal antibiotics, maternal side-effects (all), mater-
nal nausea, maternal vomiting, maternal diarrhoea, other mater-
nal side-effects, postpartum haemorrhage, chorioamnionitis, en-
dometritis, maternal antibiotics, serious maternal complications
(e.g. intensive care unit admission, septicaemia but excluding uter-
ine rupture), maternal death, woman not satisfied, and caregiver
not satisfied.
6. Vaginal isosorbide mononitrate versus Foley catheter
One study compared vaginal isosorbide mononitrate (IMN) versus
Foley catheter (Rezk 2014). See Summary of findings 6.
Primary outcomes
More women who were induced using IMN rather than Foley
catheter had not achieved a vaginal delivery within 24 hours (RR
2.62, 95% CI 1.32 to 5.21, one study, 80 women, evidence graded
low, Analysis 6.1). There was no difference in the number of women
who had a caesarean section (RR 1.00, 95% CI 0.39 to 2.59, one
study, 80 women, evidence graded very low, Analysis 6.2).
The study did not report the following primary/GRADE outcomes:
uterine hyperstimulation with FHR changes, serious neonatal
morbidity or perinatal death, and serious maternal morbidity
or death.
Secondary outcomes
More women who in the IMN group compared with the Foley
catheter group received oxytocin augmentation (RR 1.65, 95% CI
1.17 to 2.32, one study, 80 women, Analysis 6.3).
The number of women may have been too small to show clear dif-
ferences for some outcomes: slightly more infants in the IMN group
had an Apgar score less than seven at five minutes (IMN: 20 out of
40, Foley catheter: 12 out of 40; RR 1.67, 95% CI 0.95 to 2.93, Analy-
sis 6.8); slightly more women experience puerperal pyrexia with
Foley catheter (IMN: five out of 40, Foley catheter: 12 out of 40; RR
0.42, 95% CI 0.16 to 1.07, Analysis 6.11); and slightly more women
experienced headaches with IMN (IMN: 10 out of 40, Foley catheter:
three out of 40; RR 3.33, 95% CI 0.99 to 11.22, Analysis 6.13).
In this study of 80 women and infants, there was no clear differ-
ence between groups for: uterine rupture (no events, Analysis 6.4);
epidural analgesia (RR 1.00, 95% CI 0.39 to 2.59, Analysis 6.5); in-
strumental vaginal delivery (RR 0.80, 95% CI 0.23 to 2.76, Analy-
sis 6.6); meconium-stained liquor (RR 2.00, 95% CI 0.19 to 21.18,
Analysis 6.7); neonatal intensive care unit admission (RR 2.50,
95% CI 0.51 to 12.14, Analysis 6.9); maternal nausea and vomiting
(RR 3.00, 95% CI 0.33 to 27.63, Analysis 6.10); palpitation (RR 2.50,
95% CI 0.51 to 12.14, Analysis 6.12); postpartum haemorrhage (RR
2.00, 95% CI 0.90 to 4.43, Analysis 6.14); and woman not satisfied
(RR 1.75, 95% CI 0.56 to 5.51, Analysis 6.15).
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The study did not report the following secondary outcomes: cervix
unfavourable/unchanged after 12 to 24 hours, uterine hyperstim-
ulation without FHR changes, neonatal encephalopathy, perina-
tal death, disability in childhood, neonatal infection, neonatal an-
tibiotics, maternal side-effects (all), maternal diarrhoea, chorioam-
nionitis, endometritis, maternal antibiotics, serious maternal com-
plications (e.g. intensive care unit admission, septicaemia but ex-
cluding uterine rupture), maternal death, and caregiver not satis-
fied.
7. Foley catheter (80 mL) versus Foley catheter (30 mL)
One study compared 80 mL Foley catheter versus 30 mL Foley
catheter (Manish 2016). See Summary of findings 7.
Primary outcomes
There was no clear difference between groups for vaginal deliv-
ery not achieved within 24 hours (RR 1.05, 95% CI 0.91 to 1.20,
one study, 154 women, evidence graded moderate, Analysis 7.1)
and caesarean section (RR 1.05, 95% CI 0.89 to 1.24, one study, 154
women, evidence graded moderate, Analysis 7.2).
The study did not report the following primary/GRADE outcomes:
uterine hyperstimulation with FHR changes, serious neonatal
morbidity or perinatal death, and serious maternal morbidity
or death.
Secondary outcomes
More women who were induced using a 30 mL Foley catheter re-
quired oxytocin augmentation (RR 0.81, 95% CI 0.66 to 0.98, one
study, 154 women, Analysis 7.3).
In this study of 154 women and infants, there was no clear differ-
ence between groups for: uterine rupture (RR 1.00, 95% CI 0.06 to
15.70, Analysis 7.4); epidural analgesia (no events, Analysis 7.5);
instrumental vaginal delivery (RR 0.92, 95% CI 0.43 to 1.95, Analy-
sis 7.6); Apgar score less than seven at five minutes (RR 1.00, 95%
CI 0.06 to 15.70, Analysis 7.7); neonatal intensive care unit ad-
mission (RR 2.00, 95% CI 0.19 to 21.60, Analysis 7.8); neonatal en-
cephalopathy (RR 3.00, 95% CI 0.12 to 72.52, Analysis 7.9); perina-
tal death (RR 3.00, 95% CI 0.12 to 72.52, Analysis 7.10); neonatal
infection (no events, Analysis 7.11); cord prolapse (other mater-
nal side-effects) (no events, Analysis 7.12); postpartum haemor-
rhage (RR 0.33, 95% CI 0.01 to 8.06, Analysis 7.13); and chorioam-
nionitis (RR 0.33, 95% CI 0.04 to 3.13, Analysis 7.14).
The study did not report the following secondary outcomes: cervix
unfavourable/unchanged after 12 to 24 hours, uterine hyperstim-
ulation without FHR changes, meconium-stained liquor, disability
in childhood, neonatal antibiotics, maternal side-effects (all), ma-
ternal nausea, maternal vomiting, maternal diarrhoea, endometri-
tis, maternal antibiotics, serious maternal complications (e.g. in-
tensive care unit admission, septicaemia but excluding uterine rup-
ture), maternal death, woman not satisfied, and caregiver not sat-
isfied.
8. Vaginal PGE2 tablet versus vaginal PGE2 pessary
One study compared PGE2 (dinoprostone) vaginal tablet versus
vaginal pessary (Hassan 2014). See Summary of findings 8.
Primary outcomes
There was no clear difference between groups in the number of
women requiring a caesarean section (RR 1.09, 95% CI 0.74 to 1.60,
one study, 200 women, evidence graded very low, Analysis 8.1).
The study did not report the following primary/GRADE outcomes:
vaginal delivery not achieved within 24 hours, uterine hyper-
stimulation with FHR changes, serious neonatal morbidity or
perinatal death, and serious maternal morbidity or death.
Secondary outcomes
In this study of 200 women and infants, there was no clear differ-
ence between groups for: oxytocin augmentation (RR 1.50, 95% CI
0.81 to 2.78, Analysis 8.2); uterine hyperstimulation (FHR change
not mentioned) (RR 0.50, 95% CI 0.05 to 5.43, Analysis 8.3); uterine
rupture (RR 0.33, 95% CI 0.01 to 8.09, Analysis 8.4); Apgar score less
than seven at five minutes (RR 0.80, 95% CI 0.22 to 2.89, Analy-
sis 8.5); neonatal intensive care unit admission (RR 0.75, 95% CI
0.17 to 3.27, Analysis 8.6); neonatal infection (RR 1.00, 95% CI 0.06
to 15.77, Analysis 8.7); postpartum haemorrhage (RR 1.00, 95% CI
0.14 to 6.96, Analysis 8.8); chorioamnionitis (RR 1.00, 95% CI 0.06
to 15.77, Analysis 8.9); endometritis (RR 1.50, 95% CI 0.26 to 8.79,
Analysis 8.10); and maternal intensive care unit admission (no
events, Analysis 8.11).
The study did not report the following secondary outcomes: cervix
unfavourable/unchanged after 12 to 24 hours, epidural analgesia,
instrumental vaginal delivery, meconium-stained liquor, neonatal
encephalopathy, perinatal death, disability in childhood, neonatal
antibiotics, maternal side-effects (all), maternal nausea, maternal
vomiting, maternal diarrhoea, other maternal side-effects, mater-
nal antibiotics, maternal death, woman not satisfied, and caregiver
not satisfied.
D I S C U S S I O N
Summary of main results
Eight studies were included in this updated review (Hassan 2014;
Lokkegaard 2015; Manish 2016; Meetei 2015; Rezk 2014; Sharma
2015; Taylor 1993; Wing 1998), with a total of 707 women partic-
ipating in these studies, or the eligible subgroups within them.
Three studies compared an intervention with intravenous oxytocin:
vaginal PGE2 (Taylor 1993), vaginal misoprostol (Wing 1998), and
Foley catheter (Meetei 2015). One study compared double-bal-
loon catheter with vaginal PGE2 (Lokkegaard 2015), one compared
oral mifepristone with Foley catheter (Sharma 2015), and one tri-
al compared vaginal isosorbide mononitrate (a nitric oxide donor)
with Foley catheter (Rezk 2014). One study compared 80 mL Foley
catheter with 30 mL Foley catheter (Manish 2016), and one study
compared vaginal PGE2 pessary with vaginal PGE2 tablet (Hassan
2014).
The available evidence from randomised controlled trials relating
to methods of induction of labour for women with a prior caesarean
section is inadequate. The available studies are underpowered to
detect clinically relevant differences in the primary and secondary
outcome measures, and many important outcomes were not re-
ported. As the studies compared different methods of labour induc-
tion, no meta-analysis was possible.
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No clear differences were found between vaginal PGE2 and intra-
venous oxytocin for the outcomes reported by Taylor 1993 (42
women): caesarean section, serious neonatal morbidity or perina-
tal death, serious maternal morbidity or death, uterine rupture,
epidural analgesia, instrumental vaginal delivery, and Apgar score
less than seven at five minutes.
One woman who received vaginal misoprostol rather than intra-
venous oxytocin had a uterine rupture and one had a uterine dehis-
cence, prompting Wing 1998 to prematurely end the trial. Despite
this, there was no clear difference between groups, possibly due to
the small number of participants. None of our other prespecified
primary or secondary outcomes were reported in this study of 38
women.
One study comparing Foley catheter with intravenous oxytocin in
a study of 53 women (Meetei 2015) found no difference between
groups for all reported primary and secondary outcomes: vaginal
delivery within 24 hours, uterine stimulation with fetal heart rate
changes, caesarean section, oxytocin augmentation, uterine rup-
ture, instrumental vaginal delivery, postpartum haemorrhage, and
chorioamnionitis.
There was no clear difference between women who were induced
using a double-balloon catheter versus vaginal PGE2 for caesarean
section and admission to the neonatal unit in Lokkegaard 2015 (26
women) for the outcomes reported: caesarean section, and admis-
sion to neonatal unit. 'Failed induction' was reported, however this
combined women who had begun labour between randomisation
and induction, as well as women who had not delivered 48 hours
after induction, so it was not considered meaningful to include this.
No other primary or secondary outcomes were reported.
None of the primary outcomes were reported by Sharma 2015 (107
women). Women induced with oral mifepristone received less oxy-
tocin augmentation than those induced with Foley catheter. There
were slightly fewer cases of uterine rupture in the mifepristone
group, however this was not a clear difference between groups.
One study comparing induction with vaginal isosorbide monon-
itrate (IMN) versus Foley catheter (80 women, Rezk 2014) found
that fewer women induced with isosorbide mononitrate achieved
a vaginal delivery within 24 hours. More women induced with IMN
required oxytocin augmentation. There were no clear differences
for the other reported outcomes: caesarean section, uterine rup-
ture, epidural analgesia, instrumental vaginal delivery, meconi-
um-stained liquor, Apgar score less than seven at five minutes,
neonatal intensive care unit admission, maternal nausea and vom-
iting, puerperal pyrexia, palpitation, headache, postpartum haem-
orrhage, and woman not satisfied. There were slightly more infants
with an Apgar score less than seven at five minutes in the IMN group,
slightly more women experienced puerperal pyrexia in the Foley
catheter group, and slightly more women experienced headaches
with IMN, however the low number of participants meant that these
were not clear differences between the groups of women.
Manish 2016 compared 80 mL Foley catheter with 30 mL Foley
catheter (154 women). There was no clear difference between
groups for the primary outcomes: vaginal delivery not achieved
within 24 hours and caesarean section. More women who were
induced using a 30 mL Foley catheter required oxytocin augmen-
tation. There were no clear differences in the other reported sec-
ondary outcomes: uterine rupture, epidural analgesia, instrumen-
tal vaginal delivery, Apgar score less than seven at five minutes,
neonatal intensive care unit admission, neonatal encephalopa-
thy, perinatal death, neonatal infection, cord prolapse, postpartum
haemorrhage, and chorioamnionitis.
One study of 200 women (Hassan 2014) showed no difference be-
tween induction with vaginal PGE2 pessary and vaginal PGE2 tablet
for any of the reported outcomes: caesarean section, oxytocin aug-
mentation, uterine hyperstimulation (FHR change not mentioned),
uterine rupture, Apgar score less than seven at five minutes, neona-
tal intensive care unit admission, neonatal infection, postpartum
haemorrhage, chorioamnionitis, endometritis, and maternal inten-
sive care unit admission.
Overall completeness and applicability of evidence
There is insufficient information available from randomised trials
to inform the optimal method of induction of labour in women with
a prior caesarean birth. Several of the studies were at high risk of
bias, and did not report important outcomes.
Quality of the evidence
All of the trials included in this review had design limitations and
some had serious design limitations. It would be difficult to blind
women or health professionals to these interventions, and only one
study described blinding outcome assessors and the health profes-
sionals making clinical decisions (Manish 2016). One study had high
risk of attrition bias due to excluding a high proportion of women
from the analysis (Lokkegaard 2015). The risk of reporting bias was
high in two studies, one that reported few of the prespecified out-
comes from two arms of a four-arm study (Sharma 2015), and one
that reported only uterine rupture and was stopped prematurely
due to safety concerns (Wing 1998).
Several studies reported very few of our prespecified outcomes
(Lokkegaard 2015; Sharma 2015; Wing 1998), or did not report them
in a form that could be included in the review. Infant outcomes were
especially scarce, with none of our prespecified infant outcomes re-
ported by Meetei 2015, Sharma 2015 and Wing 1998.
Studies reported none (Sharma 2015; Wing 1998), one (Hassan
2014; Lokkegaard 2015), two (Manish 2016; Rezk 2014), or three
(Meetei 2015; Taylor 1993) of our five primary/GRADE outcomes.
Caesarean section was reported by six studies (Hassan 2014;
Lokkegaard 2015; Manish 2016; Meetei 2015; Rezk 2014; Taylor
1993), vaginal delivery not achieved within 24 hours was reported
by three studies (Manish 2016; Meetei 2015; Rezk 2014), uterine hy-
perstimulation with fetal heart rate changes was reported by one
study (Meetei 2015), and the composite outcomes serious neona-
tal morbidity or perinatal death, and serious maternal morbidity or
death were reported by one study (Taylor 1993).
The GRADE level of evidence for outcomes were: moderate (vagi-
nal delivery not achieved within 24 hours, and caesarean section in
Manish 2016), low (vaginal delivery not achieved within 24 hours,
uterine hyperstimulation with fetal heart rate changes, and cae-
sarean section in Meetei 2015; vaginal delivery not achieved within
24 hours in Rezk 2014; caesarean section, serious neonatal morbid-
ity or perinatal death, and serious maternal morbidity or death in
Taylor 1993), and very low (caesarean section in Lokkegaard 2015;
caesarean section in Rezk 2014; caesarean section in Hassan 2014).
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Decisions to downgrade the evidence were based on small sam-
ple sizes in every comparison, and high risk of bias in some stud-
ies (Hassan 2014; Lokkegaard 2015; Meetei 2015; Rezk 2014; Tay-
lor 1993). GRADE could not be assessed for misoprostol versus oxy-
tocin (Wing 1998) or mifepristone versus Foley catheter (Sharma
2015), because none of the prespecified GRADE outcomes were re-
ported.
Potential biases in the review process
The assessment of risk of bias involves subjective judgements. This
potential limitation is minimised by following the procedures in the
Cochrane Handbook for Systematic Reviews of Interventions (Hig-
gins 2011a) with review authors independently assessing studies
and resolving any disagreement through discussion, and if required
involving a third assessor in the decision.
Agreements and disagreements with other studies or
reviews
While there is limited information available from randomised trials,
lower-quality evidence is available from observational studies.
In a large retrospective population-based study, Lydon-Rochelle
2001 evaluated the risk of uterine rupture among women with a
prior caesarean birth, comparing the risks following the sponta-
neous onset of labour, as well as following induction of labour (us-
ing both prostaglandin and other methods to induce labour). Where
labour occurred spontaneously, the risk of uterine rupture was re-
ported to be 5.2 per 1000 women (56 of 10,789 women), increasing
to 7.7 per 1000 women (15 of 1960 women) where labour was in-
duced with “non-prostaglandin” methods, and further increasing
to 24.5 per 1000 women (nine of 366 women) where labour was in-
duced with prostaglandin preparations. When expressed as a risk
ratio (RR) comparing the chance of uterine rupture among women
who had a repeat elective caesarean section, spontaneous labour
increased the chance of rupture by three-fold (RR 3.3, 95% con-
fidence interval (CI) 1.8 to 6.0), induction with non-prostaglandin
methods by almost five-fold (RR 4.9, 95% CI 2.4 to 9.7), and induc-
tion with prostaglandin preparations by over 15.5-fold (RR 15.6,
95% CI 8.1 to 30.0). Specific information was not presented for dif-
ferent prostaglandin preparations (for example, PGE2, or misopros-
tol).
The US-based NICHD group conducted a prospective evaluation
of women with a prior caesarean birth (Landon 2004). In this
study, induction of labour following the use of prostaglandin med-
ication was associated with a non-significant increase in risk of
uterine rupture when compared with mechanical methods of in-
duction, for example, the Foley catheter (risk of uterine rupture
140 per 10,000 inductions following PGE2 compared with 89 per
10,000 inductions following mechanical dilation of the cervix with
a Foley catheter) (Landon 2004). In contrast, Scottish data from
more than 36,000 women with a prior caesarean birth, of whom
4600 women had labour induced with prostaglandins, demonstrat-
ed an increased risk of uterine rupture and subsequent perinatal
death following prostaglandin induction (risk of uterine rupture
4.5 per 10,000 non-induced labours versus 11 per 10,000 labours
induced with prostaglandins in women with a prior caesarean)
(Smith 2004). Raviasia et al conducted a retrospective cohort study
reviewing all births between 1992 and 1998 in a Canadian hospital
(Ravasia 2000). In this series, of the 172 women who underwent in-
duction with prostaglandins, five suffered a uterine rupture (2.9%),
compared with one of 129 in women who were induced with a Fo-
ley catheter (0.78%), and two of 274 women who did not require
cervical ripening (0.73%). In a similar study evaluating mechanical
cervical dilation in women with a prior caesarean section, Bujold
2004 demonstrated a similar risk of uterine rupture between Foley
catheter induction and spontaneous onset of labour (1.78% versus
1.2%).
The risk associated with uterine scar rupture following the use
of misoprostol is less well documented. Misoprostol is an oral
prostaglandin E1 analogue, licensed for use in the treatment of
gastric ulcer disease. There is increasing recognition of its use
as a prostaglandin agent to induce labour following oral, vaginal
and buccal administration (Alfirevic 2006; Hofmeyr 2010; Muzonzi-
ni 2004). However, its use to induce labour in women with a previ-
ous caesarean has been questioned, with several case reports indi-
cating an increased risk of uterine rupture (Bennett 1997; Choy-Hee
2001; Cunha 1999; Phillips 1996; Plaut 1999).
While there are documented potential risks associated with induc-
tion of labour among women with a previous caesarean section, in-
duction of labour is considered by many to be preferable to a repeat
elective caesarean section. In an Australian survey of practice relat-
ing to care of women with a prior caesarean section in a subsequent
birth, two-thirds of obstetrician respondents indicated that induc-
tion of labour was preferable to a repeat elective caesarean (Dodd
2003). While manufacturers of both oxytocin and PGE2 specifically
list previous caesarean as a contraindication to use in their prod-
uct information brochures, almost two-thirds of Australian obste-
tricians (Dodd 2003) and 25% of Canadian obstetricians (Brill 2003)
use vaginal PGE2 in this setting. Additionally, 80% of Australian ob-
stetricians use oxytocin in women with a previous caesarean birth
(Dodd 2003). These figures are similar to those reported in England,
where 76% of obstetricians would consider use of prostaglandin
analogues, and 86% of consultants would use oxytocin to induce
labour in women with a previous caesarean birth (Gupta 2011).
A U T H O R S '   C O N C L U S I O N S
Implications for practice
There is insufficient information available from randomised con-
trolled trials to inform clinical decisions regarding the optimal
method of induction of labour in women with a prior caesarean
birth. For women with an unfavourable cervix who require induc-
tion of labour, the risks and benefits of mechanical and pharmaco-
logic options of cervical ripening, as well as labour induction and
augmentation need to be considered. Whilst the data in this review
are insufficient to inform practice in terms of the best method of in-
duction for women with a prior caesarean, it is important to high-
light that one study, which used misoprostol, was stopped early
due to serious complications associated with its use.
Implications for research
Appropriately designed and conducted randomised trials are re-
quired to evaluate methods of induction of labour for women who
have had a prior caesarean birth, including evaluation of mechani-
cal methods of induction, with adequate reporting of clinically rel-
evant maternal and infant outcomes. As these are not likely to be
undertaken due to results from previous reports, and if undertak-
en are likely to be underpowered to evaluate the risk of infrequent
but serious adverse outcomes, we suggest adequately powered
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prospective cohort studies. These studies could compare methods
believed to provide effective induction of labour with low risk of se-
rious harm, and report the outcomes identified as important in this
review.
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Methods 2-arm RCT
Participants Setting: large Governmental hospital, Saudi Arabia. February 2009-March 2013
Inclusion criteria: women with a previous CS, a live singleton fetus (37-42 weeks of gestation) in cephal-
ic presentation and a reactive non-stress test, BS of ≤ 7 before onset of labour, no spontaneous contrac-
tions (< 4 contractions within 20 min)
Exclusion criteria: women in active labour or with uterine surgery other than lower segment CS, rup-
tured membranes, chorioamnionitis, antepartum haemorrhage, contraindication to prostaglandins
use (e.g. bronchial asthma or glaucoma), contraindication to vaginal delivery, nonvertex presentation,
multiple pregnancy, major fetal anomalies or demise
Interventions Experimental intervention: single dose of dinoprostone 10 mg sustained-release vaginal pessary
(Propess; controlled Therapeutics (Scotlantd) Ltd., East Kilbride, UK) into the posterior vaginal fornix.
The dinoprostone pessary releases at a steady rate (0.3 mg/h). It remained in the vagina for up to 24
h, as recommended by the manufacturer. It was removed if it was still present 24 h after placement, if
a worrisome fetal heart rate pattern persisted, or if the woman had efficient uterine contractions (3-4
contractions in 10 min). Total number randomised: n = 100
Comparison intervention: 1.5 mg dinoprostone vaginal tablet (Prostin E2; Parmacia & Upjohn, Puurs,
Belgium) into the posterior vaginal fornix for a maximum of 3 doses with 6-hourly intervals between
each dose. Before application of each dose, vaginal examination to ascertain the BS and CTG was per-
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formed to assess fetal well-being and frequency of uterine contractions. Total number randomised: n =
100
Outcomes Primary outcome: vaginal delivery rate. Secondary outcomes: induction to delivery time, maternal sat-
isfaction score for the birth process obtained within 24 h of delivery (a VAS of 0-10, with a greater score
denoting better satisfaction), maternal and neonatal complications
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk “Women included in this study were randomly allocated into two equal
groups”, no description of random sequence generation
Allocation concealment
(selection bias)
Unclear risk No allocation concealment described
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk “The study was open labelled; thus, women and clinicians were aware of the
treatment allocation scheme.”
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Open-label study, no mention of blinding outcome assessment
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk All women appear to be accounted for
Selective reporting (re-
porting bias)
Low risk Assessed from published report with no protocol available, however outcomes
were comprehensively reported
Other bias Low risk Analysis was done by ITT. Baseline characteristics, including indications for
labour induction, were similar between groups
Hassan 2014  (Continued)
 
 
Methods 2-arm multicentre RCT, with adequate randomisation
Participants Setting: 7 labour wards in Denmark, December 2002-September 2005
Inclusion criteria: pregnant women with intact fetal membranes, cephalic position and unfavourable
cervix, with indications for induction of labour (e.g. prolonged pregnancy (> 42 weeks’ gestation), pre-
eclampsia/hypertension, placental insufficiency, gestational diabetes mellitus and twins). Women with
previous CSs were included (and data were presented as a subgroup of all women)
Exclusion criteria: spontaneous labour, rupture of membranes, placenta previa, acute fetal distress,
specific vaginal/cervical infections (e.g. group-B Streptococcus, Condyloma and acute herpes), asthma,
glaucoma and latex allergy
Interventions Experimental intervention: double-balloon catheter inserted through the cervical canal with 80 mL
of saline installed stepwise in the uterine balloon and 80 mL saline in the cervicovaginal balloon. Re-
moved after 12 h, followed by amniotomy. Stimulation with oxytocin 2-3 h after amniotomy was al-
Lokkegaard 2015 
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lowed (10 IU) oxytocin/500 mL saline administered intravenously at 20 mL/h, increasing up to 180 mL/
h)
Failed induction = if the BS had increased since the randomisation (BS > 6), if the catheter insertion was
not achieved, if amniotomy could not be performed within 4 h after removal of the catheter. Total num-
ber randomised: n = 13 with previous CS (4 later excluded: 1 not VBAC, 3 "failed induction") (n = 412 in
total)
Control/comparison intervention: vaginal PGE2 (dinoprostone) 3 mg vaginal tablet Amniotomy or sec-
ond dinoprostone tablet after 4-5 h
Stimulation with oxytocin 2-3 h after amniotomy was allowed (dose/regime as in experimental group)
Failed induction = if amniotomy could not be achieved and if labour was not established within 48 h af-
ter the first dinoprostone administration
Total number randomised: n = 13 with previous CS (6 later excluded: 1 not VBAC, 5 "failed induction")
(n = 413 in total)
Outcomes Rate of failed inductions, median induction delivery time (hours), CS frequency, admission to neonatal
unit (other outcomes may be available from the study authors, e.g. Apgar score, assisted delivery)
Notes HW emailed Dr Lokkegaard requesting additional data on outcomes: vaginal delivery, assisted vaginal
delivery, and Apgar score < 7 at 5 min. These were reported for all women but not the subset who had
a previous CS, by ITT. We received a response, with incomplete additional data, inconsistent with the
published report. In correspondence, Dr Lokkegaard reported that all women in the subset of women
with a prior CS were 37 weeks of gestation or more.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated, stratified for parity and department
Allocation concealment
(selection bias)
Low risk Randomised by a telephone automatic voice-response randomisation system
administered from the Perinatal Epidemiology Research Unit, Aarhus Universi-
ty Hospital, Denmark
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk Blinding was not possible for these interventions. Knowledge of the interven-
tion may have influenced clinical decision-making
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not mentioned
Incomplete outcome data
(attrition bias) 
All outcomes
High risk Women who went into spontaneous labour before induction, who were not in
labour after 48 h, or who had been coded as VBAC in error were classed as ‘fail-
ure’ and excluded from the results. There were 13 women randomised to each
group, however results for only 10 are reported in the publication, and in cor-
respondence from the author additional 'failures' were identified. In the PGE2
group, 2 women began labour before induction, 3 were not in labour after 48 h,
and 1 was wrongly coded as VBAC. In the balloon group, 3 began labour before
induction, 1 was not VBAC and 0 were not in labour after 48 h. Unfortunately,
despite additional information from the study authors, there were still missing
data on outcomes, and we were unable to add the excluded women in an ITT
analysis
Lokkegaard 2015  (Continued)
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Selective reporting (re-
porting bias)
Unclear risk The subset of participants with a previous VBAC were not the primary focus of
this study, so few outcomes are reported for these women
Other bias High risk Groups were similar at baseline. However more women in the catheter group
went into spontaneous labour between recruitment and induction, potentially
introducing bias. The primary endpoints of the full study are reported by both
ITT and per-protocol analyses, showing that a large number of women did not
receive the allocated treatment.
Lokkegaard 2015  (Continued)
 
 
Methods 2-arm RCT, with adequate randomisation
Participants Describe setting: a large tertiary centre in South India, which carries out ˜15,000 deliveries every year.
October 2011-December 2013
Inclusion criteria: pregnant women who previously had a lower segment CS and now have a singleton
cephalic presentation after at least 36 completed weeks, not in labour, with intact membranes and BS
of < 6
Exclusion criteria: women who had endometritis in a previous pregnancy, inter-delivery interval of < 18
months, extension of the uterine incision onto upper segment at the previous CS and an estimates fetal
weight of ≥ 4 kg and women with a previous preterm CS
Interventions Experimental intervention: a 16 Fr Foley catheter was introduced into the cervix beyond the internal os
and the bulb inflated with 80 mL of sterile water
Total number randomised: n = 77
Comparison intervention: a 16 Fr Foley catheter was introduced into the cervix beyond the internal os
and the bulb inflated with 30 mL of sterile water
Total number randomised: n = 77
The Foley catheter was folded and leN in the vagina for 12 h, after which it was removed. Assessment
of the cervix and artificial rupture of membranes was done at the time of catheter removal or earlier if
the catheter expelled spontaneously. All women were monitored continuously with an electronic fetal
monitor. Oxytocin for augmentation or induction was considered if women did not have regular uterine
contractions lasting for 30 seconds, every 3 min
Outcomes Primary: percentage of women achieving vaginal delivery within 24 h of induction
Secondary: effectiveness: number of women delivering vaginally in 12 h, BS at amniotomy, duration
from induction to delivery, delivery by CS, need for augmentation with oxytocin, number of units of
oxytocin used. Maternal complications: uterine rupture, scare dehiscence, postpartum haemorrhage,
abruption placentae, chorioamnionitis. Neonatal complications: Apgar < 7 at 5 min, cord pH < 7.1,
neonatal intensive care unit admission, neonatal encephalopathy, neonatal sepsis
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk “Generated with permuted block randomisation of sizes two, four and six us-
ing SAS 9.3.1.”
Manish 2016 
Methods of term labour induction for women with a previous caesarean section (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
36
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Allocation concealment
(selection bias)
Low risk “Serially numbered, opaque, sealed envelopes containing the allocated group
were opened in a central research office after confirming that the partici-
pant was eligible for the study. The treating doctor had not access to the en-
velopes."
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Low risk It is not described as blinded: the personnel responsible for inserting and re-
moving the Foley catheter would presumably be aware of the group alloca-
tion. However, women are likely to have been unaware of which group they
were in. However, it does say that, “The decision to perform CS was leN to the
discretion of the obstetrician managing the labour ward who was unaware of
the group allocation”, so the impact of imperfect blinding due to the proce-
dure was minimised.
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk “Data on baseline characteristics and outcomes were collected by research of-
ficers who were unaware of the allocated group.”
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk All women appear to be accounted for. 1 woman in each group inadvertently
received the wrong allocation, and it’s unclear which group these women were
analysed with: the ITT intervention, or the intervention they received
Selective reporting (re-
porting bias)
Unclear risk Protocol available: some prespecified outcomes were not reported: uterine hy-
perstimulation with RHR change, meconium-stained liquor, and satisfaction of
caregiver and mother
Other bias Low risk Similar baseline characteristics, e.g. BS at induction, and indication for induc-
tion
Manish 2016  (Continued)
 
 
Methods 2-arm RCT, with adequate randomisation
Participants Setting: Chandigarh, India. July 2004–November 2005
Inclusion criteria: pregnant women with a previous low transverse CS, singleton live pregnancy with
cephalic presentation, period of gestation > 28 weeks and BS < 5 were included in the study, with un-
favourable cervix admitted for induction of labour.
Exclusion criteria: previous classical or T-shaped incision, unknown scar, transfundal uterine surgery,
medical or obstetric complications that preclude vaginal delivery, placenta previa, low lying placenta,
undiagnosed vaginal bleeding, maternal heart disease, premature/preterm premature rupture of mem-
branes, interval between previous CS and present pregnancy/conception < 6 months, cervicovaginal in-
fection, history of unclean vaginal examination and history of infection in previous CS
Interventions Experimental intervention: cervical ripening with Foley catheter balloon inflated with 30 mL of sterile
saline. Catheter inserted and inflated, observed for 12 h, then BS was rechecked or earlier if Foley ex-
pelled before 12 h. Oxytocin started after 12 h, if the woman was not yet in active labour (starting at 1
mU/min and increasing up to a maximum of 32 mU/min). Total number randomised: n = 30 (26 out of
30 were 37 weeks' gestation or more)
Control/comparison intervention: cervical ripening with low dose IV oxytocin (starting at 1 mU/min and
increasing if contractions were not frequent after 1 hour). After 12 h BS was rechecked, and oxytocin for
induction or augmentation was increased as in the Foley group up to a maximum of 32 mU/min. Total
number randomised: n = 30 (27 out of 30 were 37 weeks' gestation or more)
Outcomes BS before and after 12 h of ripening, percentage and time interval of women entering spontaneous
labour, method of delivery, induction-delivery interval, complications, neonatal outcome
Meetei 2015 
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Notes The inclusion criteria is from 28 weeks GA, and the published report states that the majority of women
were between 38 and 40 weeks. HW contacted the study author to request data for women from 37
weeks GA onwards. In personal correspondence, Dr Meetei reported that 26 out of 30 women in the Fo-
ley-catheter group, and 27 out of 30 in the oxytocin group were 37 weeks' gestation or more, and pro-
vided data for this subgroup of women
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Used Tippets random number table
Allocation concealment
(selection bias)
Unclear risk Not described
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk Not described. Unlikely, given the characteristics of the different methods
of induction being compared. This may have affected clinical decisions and
therefore introduced bias
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not described
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk All women appear to be accounted for. There is no mention of women drop-
ping out of the study
Selective reporting (re-
porting bias)
Unclear risk Assessed from published report, without protocol. It is unclear whether all pre-
specified outcomes were reported
Other bias Low risk Groups were comparable at baseline. No power calculation is reported
Meetei 2015  (Continued)
 
 
Methods 2-arm RCT
Participants Describe setting: Egypt
Inclusion criteria: the study was conducted on 80 healthy pregnant women with previous 1 lower seg-
ment CS at 37 weeks and beyond, with a BS of ≤ 6, intact membranes, reactive non-stress test, normal
umbilical arterial Doppler indices, absence of labour and willingness of women to participate in the
study. The indications for the induction of labour were pregnancy-induced hypertension, oligohydram-
nios, intrauterine growth restrictions and controlled diabetes mellitus
Exclusion criteria: women with intrauterine fetal death, twins pregnancy, polyhydramnios, placenta
previa, severe anaemia, severe hypertension, uncontrolled diabetes, coagulopathy and any contraindi-
cation for the labour induction were excluded from the study
Interventions Experimental intervention: intracervical Foley catheter was inserted, inflated and placed on traction.
Under aseptic conditions, with the women lying in the lithotomy
position, the cervix was assessed and Foley catheter No. 14-16 Fr was inserted into the endocervical
canal, beyond the internal os and the balloon was inflated with 50-60 mL of normal saline. The catheter
was strapped to the thigh with gentle traction. The catheter was checked for its position and the trac-
tion at 3-6 h intervals. The catheter was either removed at 12 h or expelled spontaneously and it was
Rezk 2014 
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checked whether the BS had improved or whether a spontaneous rupture of the membranes had oc-
curred. Total number randomised: n = 40
Comparison intervention: women received moistened 1 tablet of isosorbide mononitrate 40 mg (Mono-
mak, October Pharma, Egypt) inserted into the posterior fornix of the vagina once. Total number ran-
domised: n = 40
Women were examined regularly at 3 h, 6 h, 9 h, 12 h and 24 h after starting the method of induction
to evaluate the change in BS. Vital signs were monitored every 30 min. AROM was performed for all
women when their cervical dilatation reached 3-4 cm and IV oxytocin infusion was started if there was
no efficient uterine contractions. An oxytocin infusion was started at 2 mU/min and increased in incre-
ments of 1-2 mU/min at 15-30 min intervals as needed to achieve adequate uterine contraction pattern
(≥ 200 MVU). Opiate and epidural analgesia was given on the woman’s request and at the discretion of
the obstetrician. Continuous CTG was done during delivery and the modified WHO partograph was fol-
lowed up for the labour management)
Outcomes Primary outcome measures included changes in BS, time from initiation till the onset of labour, the
induction to delivery interval, the mode of delivery and the length of the second and third stages of
labour. Maternal adverse effects, acceptability and neonatal outcome (Apgar score at 5 min, neonatal
weight and admission to neonatal intensive care unit) were recorded as secondary outcomes.
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation in 1:1 ratio was carried out using computer-generated simple
random tables
Allocation concealment
(selection bias)
Unclear risk Not described
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk It was not possible to blind the study participants from knowledge of which in-
tervention a participant received because methods were clearly different
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not described
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Flow diagram, all women accounted for
Selective reporting (re-
porting bias)
Unclear risk This study was assessed from a published report without access to the proto-
col, so we do not know if all prespecified outcomes were reported
Other bias Low risk Groups appear to be comparable at baseline
Rezk 2014  (Continued)
 
 
Methods 4-arm RCT, with adequate randomisation (only 2 arms are reported in the poster abstract giving results
of the study)
Participants Setting: India, 2012-2014
Sharma 2015 
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Inclusion criteria: pregnant women, 40 weeks' gestation, single cephalic presentation, 1 previous low
segment CS. Postdates (gestation 40 weeks 5 days)
Exclusion criteria: described in the study protocol as: interconceptional period less than 18 months, es-
timated fetal birthweight > 4 kg, poor modified bio-physical profile (amniotic fluid index), poor dating
(not sure of dates, no ultrasonography in first trimester or 2 serial ultrasounds 4 weeks apart in second
trimester), premature rupture of membranes/chorioamnionitis, evidence of fetal distress at admission,
intrauterine fetal death, any maternal disease, i.e. hypertension, diabetes, renal disease, liver disease,
cardiac disease, epilepsy or any chronic medication, any contraindication for vaginal delivery (cepha-
lo-pelvic disproportion ruled out), type of CS not known (classical or low segment)
Interventions In the study protocol, the groups are listed as:
Comparator: cervical sweeping and stretching at 40 weeks + 5 days
Intervention 1: single dose mifepristone (200 mg) orally at 40 weeks + 5 days
Intervention 2: single dose mifepristone (400 mg) orally at 40 + 5
Intervention 3: transcervical Foley catheter with 30 mL normal saline inserted at 40 + 5
However, the poster abstract reports intervention 2 versus intervention 3, and does not mention the
other 2 arms of the study:
Experimental intervention: single dose mifepristone (400 mg) orally at 40 + 5. All women were re-
assessed 24 h and 48 h later. If BS > 6, amniotomy was done, followed by oxytocin infusion. If after 48 h,
BS was < 6, induction of labour was done with oxytocin infusion. Total number randomised: n = 57
Control/comparison intervention: transcervical Foley catheter with 30 mL normal saline inserted at 40
+ 5. Total number randomised: n = 50
Outcomes Spontaneous onset of labour, duration of labour, need and amount of oxytocin required, scar dehis-
cence, incidence of CS, neonatal outcomes (pH of cord, hypoglycaemia, intensive care unit admission)
Notes HW contacted the study authors, requesting additional information on the methodology (how blinding
was achieved), and results of the 2 arms described in the protocol but not in the published reports. No
response was received
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Described as “computer generated randomisation” in the study protocol, not
described in the study report
Allocation concealment
(selection bias)
Unclear risk Described as “sequentially numbered, sealed, opaque envelopes” in the study
protocol, not described in the study report
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk Described as “double blind double dummy” in the study protocol, but the de-
scription does not fit with having a fake Foley catheter. Not described in the
study report
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Described as “double blind double dummy” in the study protocol. Not de-
scribed in the study report
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk All women recruited appear to be accounted for in the results. However, the
omission of 2 arms of the study may suggest bias
Sharma 2015  (Continued)
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Selective reporting (re-
porting bias)
High risk The protocol described a 4-arm study, but only 2 arms were reported in the
publication. The brief poster abstract does not report any prespecified neona-
tal outcomes, and reports only 2-arms of the 4 comparison groups set out in
the protocol
Other bias High risk The inconsistencies between the study protocol and published report (such as
the omission of 2 arms of the study, information on the methodology, and pre-
specified outcomes) suggest that this study is at high risk of bias
Sharma 2015  (Continued)
 
 
Methods Prospective randomised trial; sealed, numbered envelopes; no sample size calculation
Participants Setting: UK
Women requiring labour induction due to prolonged pregnancy or pre-eclampsia, 1 previous preg-
nancy delivered by lower segment CS, singleton in cephalic presentation, GA ≥ 37 weeks, BS < 9, no
cephalopelvic disproportion anticipated
Interventions Amniotomy and IV oxytocin (n = 21) versus 2.5 mg vaginal PGE2 pessary, followed by amniotomy 3 h
later + oxytocin (if necessary) 6 h later (n = 21)
Outcomes Induction to delivery time, analgesia, mode of delivery, uterine rupture
Notes Only half of the women included had an unfavourable cervix (BS < 6)
1 uterine rupture in PGE 2 group (after oxytocin) reported in abstract Sellers 1988 (see Taylor 1993)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk "predetermined code envelope."
Allocation concealment
(selection bias)
Low risk Sealed envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk Not feasible
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Blinding was not described in the report
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Data of all women included were reported, no ITT analysis done
Selective reporting (re-
porting bias)
Unclear risk Published report includes expected outcomes, but no outcome measures were
prespecified in the methods section
Other bias Low risk The baseline characteristics were comparable between the groups
Taylor 1993 
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Methods Prematurely terminated RCT, due to safety concerns
Participants Setting: USA
Women with a singleton pregnancy in cephalic presentation with 1 prior CS were eligible for inclusion
Interventions 25 μg vaginal misoprostol every 6 h (maximum of 4 doses) (n = 17) versus IV oxytocin "per a standard-
ised infusion protocol" (dose/regime not reported) (n = 21)
Outcomes Not described in detail, included uterine tachysystole, hypertonus, hyperstimulation syndrome, uter-
ine dehiscence (defined at laparotomy or digital examination), uterine rupture (that required emer-
gency laparotomy)
Notes 2 uterine ruptures occurred in the misoprostol group and the trial was ended prematurely due to safety
concerns
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Method of sequence generation not described
Allocation concealment
(selection bias)
Unclear risk Method not described in the report
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
High risk Blinding was not feasible due to the nature of the interventions
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Blinding was not described in the report
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk There is insufficient information to judge whether all women are accounted for
Selective reporting (re-
porting bias)
High risk This report only describes the cases of uterine rupture in detail. The study was
assessed from a published report, without protocol. It is likely that other out-
comes were prespecified and these are not reported
Other bias High risk The study was terminated prematurely due to safety concerns
Wing 1998 
AROM: artificial rupture of membranes
BS: Bishop score
CS: caesarean section
CTG: cardiotocograph
Fr: French catheter scale
GA: gestational age
ITT: intention-to-treat
IU: international unit
IV: intravenous
MVU: Montevideo Units
PGE2: prostaglandin E2
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RCT: randomised controlled trial
RHR: resting heart rate
VAS: visual analogue scale
VBAC: vaginal birth after caesarean section
WHO: World Health Organization
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Arraztoa 1994 Compared, in women with a prior caesarean birth in spontaneous labour, a pharmacologic ap-
proach (oxytocin + epidural) to expectant management (spontaneous evolution). Did not compare
methods of induction for women in whom labour was induced
Ben-Aroya 2001 Not a RCT, but rather a cohort study
Hamdan 2009 Compared weekly membrane sweeping to weekly vaginal examination, did not compare 2 different
methods of cervical ripening or induction. Women did not require induction of labour
Lelaidier 1994 Mifepristone was used as a pre-induction agent, only after the women were randomised
Morales 1986 2-arm quasi-randomised trial comparing induction using oxytocin versus expectant management
for women with a previous caesarean section
Ramya 2015 Compared weekly membrane sweeps from 39 weeks GA to no intervention/expectant manage-
ment. The aim of the intervention was reducing post-term pregnancies, not induction of labour
Rayburn 1999 Compared weekly administration of cervical PGE2 gel to expectant management in women with a
prior caesarean birth, not 2 different methods of cervical ripening or induction. Women with indica-
tions for induction of labour were excluded
Sciscione 2001 Initially all women were included, subsequently women with a prior caesarean were excluded
Spallicci 2007 Women did not require induction of labour
GA: gestational age
RCT: randomised controlled trial
 
Characteristics of ongoing studies [ordered by study ID]
 
Trial name or title Management of labour in patients with previous cesarean section
Methods 2-arm randomised controlled trial, randomisation method unclear, open label
Participants Setting: Israel
Inclusion criteria: pregnant women, prelabour rupture of the membranes at > 34 weeks (ruptured
membranes in the 24 h prior to inclusion in the study), unripe cervix. Singleton in cephalic position.
1 previous CS. No contractions
Exclusion criteria: any contraindication for the vaginal delivery (i.e. placenta previa, non vertex pre-
sentation), regular uterine contractions (3-5/10 min), diagnosis of uterine rupture was made over
24 h prior to study inclusion, evidence of chorioamnionitis (T 37.6 oC with uterine tenderness and
maternal or fetal tachycardia or purulent discharge or WBC ≥ 20,000), suspected placental abrup-
tion or presence of a significant haemorrhage, non-reassuring fetal status (as determined by fetal
heart rate monitoring and/or bio-physical profile) necessitating immediate intervention
NCT02196103 
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Interventions Experimental intervention: double-balloon cervical catheter
Control/Comparison intervention: expectant management
Outcomes Vaginal delivery rate, safety (fetal heart rate, uterine haemorrhage, maternal haemodynamic
changes, uterine atony), satisfaction (maternal experience and satisfaction)
Starting date This study is not yet open for participant recruitment
Contact information Asnat Walfisch MD, Hillel YaGe Medical Center
Notes NCT02196103
NCT02196103  (Continued)
CS: caesarean section
WBC: white blood count
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 1.   Vaginal PGE2 versus intravenous oxytocin
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Caesarean section 1 42 Risk Ratio (M-H, Fixed, 95% CI) 0.67 [0.22, 2.03]
2 Serious neonatal morbidity or perinatal
death
1 42 Risk Ratio (M-H, Fixed, 95% CI) 3.0 [0.13, 69.70]
3 Serious maternal morbidity or death 1 42 Risk Ratio (M-H, Fixed, 95% CI) 3.0 [0.13, 69.70]
4 Uterine rupture 1 42 Risk Ratio (M-H, Fixed, 95% CI) 3.0 [0.13, 69.70]
5 Epidural analgesia 1 42 Risk Ratio (M-H, Fixed, 95% CI) 1.42 [0.93, 2.17]
6 Instrumental vaginal delivery 1 42 Risk Ratio (M-H, Fixed, 95% CI) 1.25 [0.39, 4.02]
7 Apgar score < 7 at 5 minutes 1 42 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 
 
Analysis 1.1.   Comparison 1 Vaginal PGE2 versus intravenous oxytocin, Outcome 1 Caesarean section.
Study or subgroup prostaglandin
E2
oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Taylor 1993 4/21 6/21 100% 0.67[0.22,2.03]
   
Total (95% CI) 21 21 100% 0.67[0.22,2.03]
Total events: 4 (prostaglandin E2), 6 (oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.72(P=0.47)  
Favours prostaglandin E2 1000.01 100.1 1 Favours oxytocin
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Analysis 1.2.   Comparison 1 Vaginal PGE2 versus intravenous
oxytocin, Outcome 2 Serious neonatal morbidity or perinatal death.
Study or subgroup prostaglandin
E2
oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Taylor 1993 1/21 0/21 100% 3[0.13,69.7]
   
Total (95% CI) 21 21 100% 3[0.13,69.7]
Total events: 1 (prostaglandin E2), 0 (oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.68(P=0.49)  
Favours experimental 1000.01 100.1 1 Favours control
 
 
Analysis 1.3.   Comparison 1 Vaginal PGE2 versus intravenous
oxytocin, Outcome 3 Serious maternal morbidity or death.
Study or subgroup prostaglandin
E2
oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Taylor 1993 1/21 0/21 100% 3[0.13,69.7]
   
Total (95% CI) 21 21 100% 3[0.13,69.7]
Total events: 1 (prostaglandin E2), 0 (oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.68(P=0.49)  
Favours experimental 1000.01 100.1 1 Favours control
 
 
Analysis 1.4.   Comparison 1 Vaginal PGE2 versus intravenous oxytocin, Outcome 4 Uterine rupture.
Study or subgroup prostaglandin
E2
oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Taylor 1993 1/21 0/21 100% 3[0.13,69.7]
   
Total (95% CI) 21 21 100% 3[0.13,69.7]
Total events: 1 (prostaglandin E2), 0 (oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.68(P=0.49)  
Favours experimental 1000.01 100.1 1 Favours control
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Analysis 1.5.   Comparison 1 Vaginal PGE2 versus intravenous oxytocin, Outcome 5 Epidural analgesia.
Study or subgroup prostaglandin
E2
oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Taylor 1993 17/21 12/21 100% 1.42[0.93,2.17]
   
Total (95% CI) 21 21 100% 1.42[0.93,2.17]
Total events: 17 (prostaglandin E2), 12 (oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.61(P=0.11)  
Favours experimental 1000.01 100.1 1 Favours control
 
 
Analysis 1.6.   Comparison 1 Vaginal PGE2 versus intravenous oxytocin, Outcome 6 Instrumental vaginal delivery.
Study or subgroup prostaglandin
E2
oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Taylor 1993 5/21 4/21 100% 1.25[0.39,4.02]
   
Total (95% CI) 21 21 100% 1.25[0.39,4.02]
Total events: 5 (prostaglandin E2), 4 (oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.37(P=0.71)  
Favours experimental 1000.01 100.1 1 Favours control
 
 
Analysis 1.7.   Comparison 1 Vaginal PGE2 versus intravenous oxytocin, Outcome 7 Apgar score < 7 at 5 minutes.
Study or subgroup prostaglandin
E2
oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Taylor 1993 0/21 0/21   Not estimable
   
Total (95% CI) 21 21 Not estimable
Total events: 0 (prostaglandin E2), 0 (oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours experimental 1000.01 100.1 1 Favours control
 
 
Comparison 2.   Vaginal misoprostol versus intravenous oxytocin
Outcome or subgroup title No. of
studies
No. of partici-
pants
Statistical method Effect size
1 Uterine rupture 1 38 Risk Ratio (M-H, Fixed, 95% CI) 3.67 [0.16, 84.66]
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Analysis 2.1.   Comparison 2 Vaginal misoprostol versus intravenous oxytocin, Outcome 1 Uterine rupture.
Study or subgroup misoprostol oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Wing 1998 1/17 0/21 100% 3.67[0.16,84.66]
   
Total (95% CI) 17 21 100% 3.67[0.16,84.66]
Total events: 1 (misoprostol), 0 (oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.81(P=0.42)  
Favours misoprostol 1000.01 100.1 1 Favours oxytocin
 
 
Comparison 3.   Foley catheter versus intravenous oxytocin
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved within 24
hours
1 53 Risk Ratio (M-H, Fixed, 95% CI) 1.47 [0.89, 2.44]
2 Uterine hyperstimulation with FHR
changes
1 53 Risk Ratio (M-H, Fixed, 95% CI) 3.11 [0.13, 73.09]
3 Caesarean section 1 53 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.45, 1.92]
4 Oxytocin augmentation 1 53 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [0.81, 1.32]
5 Uterine rupture 1 53 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Instrumental vaginal delivery 1 53 Risk Ratio (M-H, Fixed, 95% CI) 7.26 [0.39, 134.01]
7 Postpartum haemorrhage 1 53 Risk Ratio (M-H, Fixed, 95% CI) 3.11 [0.13, 73.09]
8 Chorioamnionitis 1 53 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 
 
Analysis 3.1.   Comparison 3 Foley catheter versus intravenous
oxytocin, Outcome 1 Vaginal delivery not achieved within 24 hours.
Study or subgroup Foley catheter Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Meetei 2015 17/26 12/27 100% 1.47[0.89,2.44]
   
Total (95% CI) 26 27 100% 1.47[0.89,2.44]
Total events: 17 (Foley catheter), 12 (Oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.5(P=0.13)  
Favours foley catheter 1000.01 100.1 1 Favours oxytocin
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Analysis 3.2.   Comparison 3 Foley catheter versus intravenous
oxytocin, Outcome 2 Uterine hyperstimulation with FHR changes.
Study or subgroup Foley catheter Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Meetei 2015 1/26 0/27 100% 3.11[0.13,73.09]
   
Total (95% CI) 26 27 100% 3.11[0.13,73.09]
Total events: 1 (Foley catheter), 0 (Oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.7(P=0.48)  
Favours foley catheter 1000.01 100.1 1 Favours oxytocin
 
 
Analysis 3.3.   Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 3 Caesarean section.
Study or subgroup Foley catheter Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Meetei 2015 9/26 10/27 100% 0.93[0.45,1.92]
   
Total (95% CI) 26 27 100% 0.93[0.45,1.92]
Total events: 9 (Foley catheter), 10 (Oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.18(P=0.85)  
Favours foley catheter 1000.01 100.1 1 Favours oxytocin
 
 
Analysis 3.4.   Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 4 Oxytocin augmentation.
Study or subgroup Foley catheter Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Meetei 2015 22/26 22/27 100% 1.04[0.81,1.32]
   
Total (95% CI) 26 27 100% 1.04[0.81,1.32]
Total events: 22 (Foley catheter), 22 (Oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.3(P=0.76)  
Favours foley catheter 1000.01 100.1 1 Favours oxytocin
 
 
Analysis 3.5.   Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 5 Uterine rupture.
Study or subgroup Foley catheter Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Meetei 2015 0/26 0/27   Not estimable
   
Total (95% CI) 26 27 Not estimable
Total events: 0 (Foley catheter), 0 (Oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours foley catheter 1000.01 100.1 1 Favours oxytocin
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Analysis 3.6.   Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 6 Instrumental vaginal delivery.
Study or subgroup Foley catheter Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Meetei 2015 3/26 0/27 100% 7.26[0.39,134.01]
   
Total (95% CI) 26 27 100% 7.26[0.39,134.01]
Total events: 3 (Foley catheter), 0 (Oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.33(P=0.18)  
Favours foley catheter 1000.01 100.1 1 Favours oxytocin
 
 
Analysis 3.7.   Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 7 Postpartum haemorrhage.
Study or subgroup Foley catheter Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Meetei 2015 1/26 0/27 100% 3.11[0.13,73.09]
   
Total (95% CI) 26 27 100% 3.11[0.13,73.09]
Total events: 1 (Foley catheter), 0 (Oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.7(P=0.48)  
Favours foley catheter 1000.01 100.1 1 Favours oxytocin
 
 
Analysis 3.8.   Comparison 3 Foley catheter versus intravenous oxytocin, Outcome 8 Chorioamnionitis.
Study or subgroup Foley catheter Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Meetei 2015 0/26 0/27   Not estimable
   
Total (95% CI) 26 27 Not estimable
Total events: 0 (Foley catheter), 0 (Oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours foley catheter 1000.01 100.1 1 Favours oxytocin
 
 
Comparison 4.   Double-balloon catheter versus vaginal PGE2
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Caesarean section 1 16 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.41, 2.32]
2 Admission to neonatal unit 1 20 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Methods of term labour induction for women with a previous caesarean section (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
49
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
 
 
Analysis 4.1.   Comparison 4 Double-balloon catheter versus vaginal PGE2, Outcome 1 Caesarean section.
Study or subgroup Double-bal-
loon catheter
Dinoprostone Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Lokkegaard 2015 5/9 4/7 100% 0.97[0.41,2.32]
   
Total (95% CI) 9 7 100% 0.97[0.41,2.32]
Total events: 5 (Double-balloon catheter), 4 (Dinoprostone)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.06(P=0.95)  
Favours catheter 1000.01 100.1 1 Favours PGE2
 
 
Analysis 4.2.   Comparison 4 Double-balloon catheter versus vaginal PGE2, Outcome 2 Admission to neonatal unit.
Study or subgroup Double-bal-
loon catheter
Dinoprostone Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Lokkegaard 2015 0/10 0/10   Not estimable
   
Total (95% CI) 10 10 Not estimable
Total events: 0 (Double-balloon catheter), 0 (Dinoprostone)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours catheter 1000.01 100.1 1 Favours PGE2
 
 
Comparison 5.   Oral mifepristone versus Foley catheter
Outcome or subgroup title No. of
studies
No. of par-
ticipants
Statistical method Effect size
1 Oxytocin augmentation 1 107 Risk Ratio (M-H, Fixed, 95% CI) 0.54 [0.38, 0.76]
2 Uterine rupture 1 107 Risk Ratio (M-H, Fixed, 95% CI) 0.29 [0.08, 1.02]
 
 
Analysis 5.1.   Comparison 5 Oral mifepristone versus Foley catheter, Outcome 1 Oxytocin augmentation.
Study or subgroup Mifepristone Foley catheter Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Sharma 2015 24/57 39/50 100% 0.54[0.38,0.76]
   
Total (95% CI) 57 50 100% 0.54[0.38,0.76]
Total events: 24 (Mifepristone), 39 (Foley catheter)  
Heterogeneity: Not applicable  
Test for overall effect: Z=3.57(P=0)  
Favours Mifepristone 1000.01 100.1 1 Favours Foley catheter
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Analysis 5.2.   Comparison 5 Oral mifepristone versus Foley catheter, Outcome 2 Uterine rupture.
Study or subgroup Mifepristone Foley catheter Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Sharma 2015 3/57 9/50 100% 0.29[0.08,1.02]
   
Total (95% CI) 57 50 100% 0.29[0.08,1.02]
Total events: 3 (Mifepristone), 9 (Foley catheter)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.93(P=0.05)  
Favours Mifepristone 1000.01 100.1 1 Favours Foley catheter
 
 
Comparison 6.   Vaginal isosorbide mononitrate versus Foley catheter
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved within
24 hours
1 80 Risk Ratio (M-H, Fixed, 95% CI) 2.63 [1.32, 5.21]
2 Caesarean section 1 80 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.39, 2.59]
3 Oxytocin augmentation 1 80 Risk Ratio (M-H, Fixed, 95% CI) 1.65 [1.17, 2.32]
4 Uterine rupture 1 80 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Epidural analgesia 1 80 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.39, 2.59]
6 Instrumental vaginal delivery 1 80 Risk Ratio (M-H, Fixed, 95% CI) 0.8 [0.23, 2.76]
7 Meconium-stained liquor 1 80 Risk Ratio (M-H, Fixed, 95% CI) 2.0 [0.19, 21.18]
8 Apgar score < 7 at 5 minutes 1 80 Risk Ratio (M-H, Fixed, 95% CI) 1.67 [0.95, 2.93]
9 Neonatal intensive care unit admis-
sion
1 80 Risk Ratio (M-H, Fixed, 95% CI) 2.5 [0.51, 12.14]
10 Maternal nausea and vomiting 1 80 Risk Ratio (M-H, Fixed, 95% CI) 3.0 [0.33, 27.63]
11 Puerperal pyrexia (other maternal
side-effects)
1 80 Risk Ratio (M-H, Fixed, 95% CI) 0.42 [0.16, 1.07]
12 Palpitation (other maternal side-
effects)
1 80 Risk Ratio (M-H, Fixed, 95% CI) 2.5 [0.51, 12.14]
13 Headache (other maternal side-ef-
fects)
1 80 Risk Ratio (M-H, Fixed, 95% CI) 3.33 [0.99, 11.22]
14 Postpartum haemorrhage 1 80 Risk Ratio (M-H, Fixed, 95% CI) 2.0 [0.90, 4.43]
15 Woman not satisfied 1 80 Risk Ratio (M-H, Fixed, 95% CI) 1.75 [0.56, 5.51]
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Analysis 6.1.   Comparison 6 Vaginal isosorbide mononitrate versus Foley
catheter, Outcome 1 Vaginal delivery not achieved within 24 hours.
Study or subgroup Isosordid
mononitrate
Foley catheter Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Rezk 2014 21/40 8/40 100% 2.63[1.32,5.21]
   
Total (95% CI) 40 40 100% 2.63[1.32,5.21]
Total events: 21 (Isosordid mononitrate), 8 (Foley catheter)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.76(P=0.01)  
Favours IMN 1000.01 100.1 1 Favours foley catheter
 
 
Analysis 6.2.   Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 2 Caesarean section.
Study or subgroup Isosordid
mononitrate
Foley catheter Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Rezk 2014 7/40 7/40 100% 1[0.39,2.59]
   
Total (95% CI) 40 40 100% 1[0.39,2.59]
Total events: 7 (Isosordid mononitrate), 7 (Foley catheter)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours IMN 1000.01 100.1 1 Favours foley catheter
 
 
Analysis 6.3.   Comparison 6 Vaginal isosorbide mononitrate
versus Foley catheter, Outcome 3 Oxytocin augmentation.
Study or subgroup Isosordid
mononitrate
Foley catheter Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Rezk 2014 33/40 20/40 100% 1.65[1.17,2.32]
   
Total (95% CI) 40 40 100% 1.65[1.17,2.32]
Total events: 33 (Isosordid mononitrate), 20 (Foley catheter)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.88(P=0)  
Favours IMN 1000.01 100.1 1 Favours foley catheter
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Analysis 6.4.   Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 4 Uterine rupture.
Study or subgroup Isosordid
mononitrate
Foley catheter Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Rezk 2014 0/40 0/40   Not estimable
   
Total (95% CI) 40 40 Not estimable
Total events: 0 (Isosordid mononitrate), 0 (Foley catheter)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours IMN 1000.01 100.1 1 Favours foley catheter
 
 
Analysis 6.5.   Comparison 6 Vaginal isosorbide mononitrate versus Foley catheter, Outcome 5 Epidural analgesia.
Study or subgroup Isosordid
mononitrate
Foley catheter Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Rezk 2014 7/40 7/40 100% 1[0.39,2.59]
   
Total (95% CI) 40 40 100% 1[0.39,2.59]
Total events: 7 (Isosordid mononitrate), 7 (Foley catheter)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours IMN 1000.01 100.1 1 Favours foley catheter
 
 
Analysis 6.6.   Comparison 6 Vaginal isosorbide mononitrate
versus Foley catheter, Outcome 6 Instrumental vaginal delivery.
Study or subgroup Isosordid
mononitrate
Foley catheter Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Rezk 2014 4/40 5/40 100% 0.8[0.23,2.76]
   
Total (95% CI) 40 40 100% 0.8[0.23,2.76]
Total events: 4 (Isosordid mononitrate), 5 (Foley catheter)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.35(P=0.72)  
Favours IMN 1000.01 100.1 1 Favours foley catheter
 
 
Analysis 6.7.   Comparison 6 Vaginal isosorbide mononitrate
versus Foley catheter, Outcome 7 Meconium-stained liquor.
Study or subgroup Isosordid
mononitrate
Foley catheter Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Rezk 2014 2/40 1/40 100% 2[0.19,21.18]
   
Favours IMN 1000.01 100.1 1 Favours foley catheter
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Study or subgroup Isosordid
mononitrate
Foley catheter Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Total (95% CI) 40 40 100% 2[0.19,21.18]
Total events: 2 (Isosordid mononitrate), 1 (Foley catheter)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.58(P=0.56)  
Favours IMN 1000.01 100.1 1 Favours foley catheter
 
 
Analysis 6.8.   Comparison 6 Vaginal isosorbide mononitrate
versus Foley catheter, Outcome 8 Apgar score < 7 at 5 minutes.
Study or subgroup Isosordid
mononitrate
Foley catheter Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Rezk 2014 20/40 12/40 100% 1.67[0.95,2.93]
   
Total (95% CI) 40 40 100% 1.67[0.95,2.93]
Total events: 20 (Isosordid mononitrate), 12 (Foley catheter)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.77(P=0.08)  
Favours IMN 1000.01 100.1 1 Favours foley catheter
 
 
Analysis 6.9.   Comparison 6 Vaginal isosorbide mononitrate versus
Foley catheter, Outcome 9 Neonatal intensive care unit admission.
Study or subgroup Isosordid
mononitrate
Foley catheter Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Rezk 2014 5/40 2/40 100% 2.5[0.51,12.14]
   
Total (95% CI) 40 40 100% 2.5[0.51,12.14]
Total events: 5 (Isosordid mononitrate), 2 (Foley catheter)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.14(P=0.26)  
Favours IMN 1000.01 100.1 1 Favours foley catheter
 
 
Analysis 6.10.   Comparison 6 Vaginal isosorbide mononitrate
versus Foley catheter, Outcome 10 Maternal nausea and vomiting.
Study or subgroup Isosordid
mononitrate
Foley catheter Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Rezk 2014 3/40 1/40 100% 3[0.33,27.63]
   
Total (95% CI) 40 40 100% 3[0.33,27.63]
Total events: 3 (Isosordid mononitrate), 1 (Foley catheter)  
Favours IMN 1000.01 100.1 1 Favours foley catheter
Methods of term labour induction for women with a previous caesarean section (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
54
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Study or subgroup Isosordid
mononitrate
Foley catheter Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Heterogeneity: Not applicable  
Test for overall effect: Z=0.97(P=0.33)  
Favours IMN 1000.01 100.1 1 Favours foley catheter
 
 
Analysis 6.11.   Comparison 6 Vaginal isosorbide mononitrate versus Foley
catheter, Outcome 11 Puerperal pyrexia (other maternal side-e=ects).
Study or subgroup Isosordid
mononitrate
Foley catheter Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Rezk 2014 5/40 12/40 100% 0.42[0.16,1.07]
   
Total (95% CI) 40 40 100% 0.42[0.16,1.07]
Total events: 5 (Isosordid mononitrate), 12 (Foley catheter)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.81(P=0.07)  
Favours IMN 1000.01 100.1 1 Favours foley catheter
 
 
Analysis 6.12.   Comparison 6 Vaginal isosorbide mononitrate versus
Foley catheter, Outcome 12 Palpitation (other maternal side-e=ects).
Study or subgroup Isosordid
mononitrate
Foley catheter Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Rezk 2014 5/40 2/40 100% 2.5[0.51,12.14]
   
Total (95% CI) 40 40 100% 2.5[0.51,12.14]
Total events: 5 (Isosordid mononitrate), 2 (Foley catheter)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.14(P=0.26)  
Favours IMN 1000.01 100.1 1 Favours foley catheter
 
 
Analysis 6.13.   Comparison 6 Vaginal isosorbide mononitrate versus
Foley catheter, Outcome 13 Headache (other maternal side-e=ects).
Study or subgroup Isosordid
mononitrate
Foley catheter Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Rezk 2014 10/40 3/40 100% 3.33[0.99,11.22]
   
Total (95% CI) 40 40 100% 3.33[0.99,11.22]
Total events: 10 (Isosordid mononitrate), 3 (Foley catheter)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.94(P=0.05)  
Favours IMN 1000.01 100.1 1 Favours foley catheter
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Analysis 6.14.   Comparison 6 Vaginal isosorbide mononitrate
versus Foley catheter, Outcome 14 Postpartum haemorrhage.
Study or subgroup Isosordid
mononitrate
Foley catheter Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Rezk 2014 14/40 7/40 100% 2[0.9,4.43]
   
Total (95% CI) 40 40 100% 2[0.9,4.43]
Total events: 14 (Isosordid mononitrate), 7 (Foley catheter)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.71(P=0.09)  
Favours IMN 1000.01 100.1 1 Favours foley catheter
 
 
Analysis 6.15.   Comparison 6 Vaginal isosorbide mononitrate
versus Foley catheter, Outcome 15 Woman not satisfied.
Study or subgroup Isosordid
mononitrate
Foley catheter Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Rezk 2014 7/40 4/40 100% 1.75[0.56,5.51]
   
Total (95% CI) 40 40 100% 1.75[0.56,5.51]
Total events: 7 (Isosordid mononitrate), 4 (Foley catheter)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.96(P=0.34)  
Favours IMN 1000.01 100.1 1 Favours foley catheter
 
 
Comparison 7.   Foley catheter 80 mL versus Foley catheter 30 mL
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved within 24
hours
1 154 Risk Ratio (M-H, Fixed, 95% CI) 1.05 [0.91, 1.20]
2 Caesarean section 1 154 Risk Ratio (M-H, Fixed, 95% CI) 1.05 [0.89, 1.24]
3 Oxytocin augmentation 1 154 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.66, 0.98]
4 Uterine rupture 1 154 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.06, 15.70]
5 Epidural analgesia 1 154 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Instrumental vaginal delivery 1 154 Risk Ratio (M-H, Fixed, 95% CI) 0.92 [0.43, 1.95]
7 Apgar score < 7 at 5 minutes 1 154 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.06, 15.70]
8 Neonatal intensive care unit admission 1 154 Risk Ratio (M-H, Fixed, 95% CI) 2.0 [0.19, 21.60]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
9 Neonatal encephalopathy 1 154 Risk Ratio (M-H, Fixed, 95% CI) 3.0 [0.12, 72.52]
10 Perinatal death 1 154 Risk Ratio (M-H, Fixed, 95% CI) 3.0 [0.12, 72.52]
11 Neonatal infection 1 154 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
12 Cord prolapse (other maternal side-ef-
fects)
1 154 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Postpartum haemorrhage 1 154 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 8.06]
14 Chorioamnionitis 1 154 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.04, 3.13]
 
 
Analysis 7.1.   Comparison 7 Foley catheter 80 mL versus Foley catheter
30 mL, Outcome 1 Vaginal delivery not achieved within 24 hours.
Study or subgroup Foley 80 mL Foley 30 mL Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Manish 2016 66/77 63/77 100% 1.05[0.91,1.2]
   
Total (95% CI) 77 77 100% 1.05[0.91,1.2]
Total events: 66 (Foley 80 mL), 63 (Foley 30 mL)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.65(P=0.51)  
Favours Foley 80 mL 1000.01 100.1 1 Favours Foley 30 mL
 
 
Analysis 7.2.   Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 2 Caesarean section.
Study or subgroup Foley 80 mL Foley 30 mL Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Manish 2016 62/77 59/77 100% 1.05[0.89,1.24]
   
Total (95% CI) 77 77 100% 1.05[0.89,1.24]
Total events: 62 (Foley 80 mL), 59 (Foley 30 mL)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.59(P=0.56)  
Favours Foley 80 mL 1000.01 100.1 1 Favours Foley 30 mL
 
 
Analysis 7.3.   Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 3 Oxytocin augmentation.
Study or subgroup Foley 80 mL Foley 30 mL Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Manish 2016 50/77 62/77 100% 0.81[0.66,0.98]
Favours Foley 80 mL 1000.01 100.1 1 Favours Foley 30 mL
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Study or subgroup Foley 80 mL Foley 30 mL Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
   
Total (95% CI) 77 77 100% 0.81[0.66,0.98]
Total events: 50 (Foley 80 mL), 62 (Foley 30 mL)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.13(P=0.03)  
Favours Foley 80 mL 1000.01 100.1 1 Favours Foley 30 mL
 
 
Analysis 7.4.   Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 4 Uterine rupture.
Study or subgroup Foley 80 mL Foley 30 mL Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Manish 2016 1/77 1/77 100% 1[0.06,15.7]
   
Total (95% CI) 77 77 100% 1[0.06,15.7]
Total events: 1 (Foley 80 mL), 1 (Foley 30 mL)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours Foley 80 mL 1000.01 100.1 1 Favours Foley 30 mL
 
 
Analysis 7.5.   Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 5 Epidural analgesia.
Study or subgroup Foley 80 mL Foley 30 mL Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Manish 2016 0/77 0/77   Not estimable
   
Total (95% CI) 77 77 Not estimable
Total events: 0 (Foley 80 mL), 0 (Foley 30 mL)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours Foley 80 mL 1000.01 100.1 1 Favours Foley 30 mL
 
 
Analysis 7.6.   Comparison 7 Foley catheter 80 mL versus Foley
catheter 30 mL, Outcome 6 Instrumental vaginal delivery.
Study or subgroup Foley 80 mL Foley 30 mL Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Manish 2016 11/77 12/77 100% 0.92[0.43,1.95]
   
Total (95% CI) 77 77 100% 0.92[0.43,1.95]
Total events: 11 (Foley 80 mL), 12 (Foley 30 mL)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.23(P=0.82)  
Favours Foley 80 mL 1000.01 100.1 1 Favours Foley 30 mL
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Analysis 7.7.   Comparison 7 Foley catheter 80 mL versus
Foley catheter 30 mL, Outcome 7 Apgar score < 7 at 5 minutes.
Study or subgroup Foley 80 mL Foley 30 mL Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Manish 2016 1/77 1/77 100% 1[0.06,15.7]
   
Total (95% CI) 77 77 100% 1[0.06,15.7]
Total events: 1 (Foley 80 mL), 1 (Foley 30 mL)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours Foley 80 mL 1000.01 100.1 1 Favours Foley 30 mL
 
 
Analysis 7.8.   Comparison 7 Foley catheter 80 mL versus Foley
catheter 30 mL, Outcome 8 Neonatal intensive care unit admission.
Study or subgroup Foley 80 mL Foley 30 mL Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Manish 2016 2/77 1/77 100% 2[0.19,21.6]
   
Total (95% CI) 77 77 100% 2[0.19,21.6]
Total events: 2 (Foley 80 mL), 1 (Foley 30 mL)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.57(P=0.57)  
Favours Foley 80 mL 1000.01 100.1 1 Favours Foley 30 mL
 
 
Analysis 7.9.   Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 9 Neonatal encephalopathy.
Study or subgroup Foley 80 mL Foley 30 mL Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Manish 2016 1/77 0/77 100% 3[0.12,72.52]
   
Total (95% CI) 77 77 100% 3[0.12,72.52]
Total events: 1 (Foley 80 mL), 0 (Foley 30 mL)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.68(P=0.5)  
Favours Foley 80 mL 1000.01 100.1 1 Favours Foley 30 mL
 
 
Analysis 7.10.   Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 10 Perinatal death.
Study or subgroup Foley 80 mL Foley 30 mL Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Manish 2016 1/77 0/77 100% 3[0.12,72.52]
   
Total (95% CI) 77 77 100% 3[0.12,72.52]
Total events: 1 (Foley 80 mL), 0 (Foley 30 mL)  
Favours Foley 80 mL 1000.01 100.1 1 Favours Foley 30 mL
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Study or subgroup Foley 80 mL Foley 30 mL Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Heterogeneity: Not applicable  
Test for overall effect: Z=0.68(P=0.5)  
Favours Foley 80 mL 1000.01 100.1 1 Favours Foley 30 mL
 
 
Analysis 7.11.   Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 11 Neonatal infection.
Study or subgroup Foley 80 mL Foley 30 mL Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Manish 2016 0/77 0/77   Not estimable
   
Total (95% CI) 77 77 Not estimable
Total events: 0 (Foley 80 mL), 0 (Foley 30 mL)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours Foley 80 mL 1000.01 100.1 1 Favours Foley 30 mL
 
 
Analysis 7.12.   Comparison 7 Foley catheter 80 mL versus Foley catheter
30 mL, Outcome 12 Cord prolapse (other maternal side-e=ects).
Study or subgroup Foley 80 mL Foley 30 mL Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Manish 2016 0/77 0/77   Not estimable
   
Total (95% CI) 77 77 Not estimable
Total events: 0 (Foley 80 mL), 0 (Foley 30 mL)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours Foley 80 mL 1000.01 100.1 1 Favours Foley 30 mL
 
 
Analysis 7.13.   Comparison 7 Foley catheter 80 mL versus
Foley catheter 30 mL, Outcome 13 Postpartum haemorrhage.
Study or subgroup Foley 80 mL Foley 30 mL Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Manish 2016 0/77 1/77 100% 0.33[0.01,8.06]
   
Total (95% CI) 77 77 100% 0.33[0.01,8.06]
Total events: 0 (Foley 80 mL), 1 (Foley 30 mL)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.68(P=0.5)  
Favours Foley 80 mL 1000.01 100.1 1 Favours Foley 30 mL
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Analysis 7.14.   Comparison 7 Foley catheter 80 mL versus Foley catheter 30 mL, Outcome 14 Chorioamnionitis.
Study or subgroup Foley 80 mL Foley 30 mL Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Manish 2016 1/77 3/77 100% 0.33[0.04,3.13]
   
Total (95% CI) 77 77 100% 0.33[0.04,3.13]
Total events: 1 (Foley 80 mL), 3 (Foley 30 mL)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.96(P=0.34)  
Favours Foley 80 mL 1000.01 100.1 1 Favours Foley 30 mL
 
 
Comparison 8.   Vaginal PGE2 pessary versus vaginal PGE2 tablet
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Caesarean section 1 200 Risk Ratio (M-H, Fixed, 95% CI) 1.09 [0.74, 1.60]
2 Oxytocin augmentation 1 200 Risk Ratio (M-H, Fixed, 95% CI) 1.5 [0.81, 2.78]
3 Uterine hyperstimulation (FHR change not
mentioned)
1 200 Risk Ratio (M-H, Fixed, 95% CI) 0.5 [0.05, 5.43]
4 Uterine rupture 1 200 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 8.09]
5 Apgar score < 7 at 5 minutes 1 200 Risk Ratio (M-H, Fixed, 95% CI) 0.8 [0.22, 2.89]
6 Neonatal intensive care unit admission 1 200 Risk Ratio (M-H, Fixed, 95% CI) 0.75 [0.17, 3.27]
7 Neonatal infection 1 200 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.06, 15.77]
8 Postpartum haemorrhage 1 200 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.14, 6.96]
9 Chorioamnionitis 1 200 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.06, 15.77]
10 Endometritis 1 200 Risk Ratio (M-H, Fixed, 95% CI) 1.5 [0.26, 8.79]
11 Maternal intensive care unit admission (se-
rious maternal complications)
1 200 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 
 
Analysis 8.1.   Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 1 Caesarean section.
Study or subgroup Pessary Tablet Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hassan 2014 36/100 33/100 100% 1.09[0.74,1.6]
   
Total (95% CI) 100 100 100% 1.09[0.74,1.6]
Total events: 36 (Pessary), 33 (Tablet)  
Favours pessary 1000.01 100.1 1 Favours tablet
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Study or subgroup Pessary Tablet Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Heterogeneity: Not applicable  
Test for overall effect: Z=0.45(P=0.66)  
Favours pessary 1000.01 100.1 1 Favours tablet
 
 
Analysis 8.2.   Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 2 Oxytocin augmentation.
Study or subgroup Pessary Tablet Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hassan 2014 21/100 14/100 100% 1.5[0.81,2.78]
   
Total (95% CI) 100 100 100% 1.5[0.81,2.78]
Total events: 21 (Pessary), 14 (Tablet)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.29(P=0.2)  
Favours pessary 1000.01 100.1 1 Favours tablet
 
 
Analysis 8.3.   Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2
tablet, Outcome 3 Uterine hyperstimulation (FHR change not mentioned).
Study or subgroup Pessary Tablet Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hassan 2014 1/100 2/100 100% 0.5[0.05,5.43]
   
Total (95% CI) 100 100 100% 0.5[0.05,5.43]
Total events: 1 (Pessary), 2 (Tablet)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.57(P=0.57)  
Favours pessary 1000.01 100.1 1 Favours tablet
 
 
Analysis 8.4.   Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 4 Uterine rupture.
Study or subgroup Pessary Tablet Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hassan 2014 0/100 1/100 100% 0.33[0.01,8.09]
   
Total (95% CI) 100 100 100% 0.33[0.01,8.09]
Total events: 0 (Pessary), 1 (Tablet)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.68(P=0.5)  
Favours pessary 1000.01 100.1 1 Favours tablet
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Analysis 8.5.   Comparison 8 Vaginal PGE2 pessary versus
vaginal PGE2 tablet, Outcome 5 Apgar score < 7 at 5 minutes.
Study or subgroup Pessary Tablet Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hassan 2014 4/100 5/100 100% 0.8[0.22,2.89]
   
Total (95% CI) 100 100 100% 0.8[0.22,2.89]
Total events: 4 (Pessary), 5 (Tablet)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.34(P=0.73)  
Favours pessary 1000.01 100.1 1 Favours tablet
 
 
Analysis 8.6.   Comparison 8 Vaginal PGE2 pessary versus vaginal
PGE2 tablet, Outcome 6 Neonatal intensive care unit admission.
Study or subgroup Pessary Tablet Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hassan 2014 3/100 4/100 100% 0.75[0.17,3.27]
   
Total (95% CI) 100 100 100% 0.75[0.17,3.27]
Total events: 3 (Pessary), 4 (Tablet)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.38(P=0.7)  
Favours pessary 1000.01 100.1 1 Favours tablet
 
 
Analysis 8.7.   Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 7 Neonatal infection.
Study or subgroup Pessary Tablet Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hassan 2014 1/100 1/100 100% 1[0.06,15.77]
   
Total (95% CI) 100 100 100% 1[0.06,15.77]
Total events: 1 (Pessary), 1 (Tablet)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours pessary 1000.01 100.1 1 Favours tablet
 
 
Analysis 8.8.   Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 8 Postpartum haemorrhage.
Study or subgroup Pessary Tablet Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hassan 2014 2/100 2/100 100% 1[0.14,6.96]
   
Total (95% CI) 100 100 100% 1[0.14,6.96]
Total events: 2 (Pessary), 2 (Tablet)  
Heterogeneity: Not applicable  
Favours pessary 1000.01 100.1 1 Favours tablet
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Study or subgroup Pessary Tablet Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Test for overall effect: Not applicable  
Favours pessary 1000.01 100.1 1 Favours tablet
 
 
Analysis 8.9.   Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 9 Chorioamnionitis.
Study or subgroup Pessary Tablet Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hassan 2014 1/100 1/100 100% 1[0.06,15.77]
   
Total (95% CI) 100 100 100% 1[0.06,15.77]
Total events: 1 (Pessary), 1 (Tablet)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours pessary 1000.01 100.1 1 Favours tablet
 
 
Analysis 8.10.   Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet, Outcome 10 Endometritis.
Study or subgroup Pessary Tablet Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hassan 2014 3/100 2/100 100% 1.5[0.26,8.79]
   
Total (95% CI) 100 100 100% 1.5[0.26,8.79]
Total events: 3 (Pessary), 2 (Tablet)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.45(P=0.65)  
Favours pessary 1000.01 100.1 1 Favours tablet
 
 
Analysis 8.11.   Comparison 8 Vaginal PGE2 pessary versus vaginal PGE2 tablet,
Outcome 11 Maternal intensive care unit admission (serious maternal complications).
Study or subgroup Pessary Tablet Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hassan 2014 0/100 0/100   Not estimable
   
Total (95% CI) 100 100 Not estimable
Total events: 0 (Pessary), 0 (Tablet)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours pessary 1000.01 100.1 1 Favours tablet
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Date Event Description
31 August 2016 New search has been performed Search updated and 12 trial new reports were identified.
For this update we have included a further six studies (from 10
reports), and excluded one study. One study is ongoing.
We have updated the methods in line with the standard methods
used by Cochrane Pregnancy and Childbirth and we have used
GRADE to assess the quality of the body of evidence.
31 August 2016 New citation required but conclusions
have not changed
No change to conclusions.
 
C O N T R I B U T I O N S   O F   A U T H O R S
For the review update, Helen West and Marta Jozwiak assessed study eligibility, methodological quality, and performed data extraction.
Helen West entered the data, conducted the GRADE assessment, produced the 'Summary of findings' tables, and drafted the review up-
date. Jodie Dodd checked the data and commented on the review.
D E C L A R A T I O N S   O F   I N T E R E S T
Jodie Dodd: none known.
Marta Jozwiak was involved in two RCTs on the topic of induction of labour but these are not eligible for inclusion in this review (the
participants had not had a previous caesarean section). She was also involved in an observational study looking at induction of labour in
women with a caesarean section (PROBAAT-S study) – this study has not yet been published but would not be eligible for inclusion in this
review as it is not a randomised controlled trial.
Helen West's contribution to this project was supported by the National Institute for Health Research, via Cochrane Programme Grant
funding to Cochrane Pregnancy and Childbirth. NIHR has no influence on the content or conclusions of this review.
S O U R C E S   O F   S U P P O R T
Internal sources• (HW) Cochrane Pregnancy and Childbirth Group, Department of Women's and Children's Health, The University of Liverpool, Liverpool,
UK.
External sources• The University of Adelaide, Discipline of Obstetrics and Gynaecology, Australia.• The Australian National Health and Medical Research Council Practitioner Fellowship, Australia.• (HW) NIHR Cochrane Programme Grant Project: 13/89/05 – Pregnancy and childbirth systematic reviews to support clinical guidelines,
UK.
D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
We have updated our methods to include the use of GRADE to assess the quality of the body of evidence and we have included 'Summary
of findings' tables.
Trials using a cluster-RCT design are now eligible for inclusion in this review (and we include methods for dealing with them) but none
were identified for this update. We also include methods for dealing with trials that have multiple-arms.
I N D E X   T E R M S
Medical Subject Headings (MeSH)
*Vaginal Birth aNer Cesarean;  Dinoprostone  [administration & dosage];  Early Termination of Clinical Trials;  Labor, Induced  [*methods];
   Misoprostol   [administration & dosage];   Oxytocics   [*administration & dosage];   Oxytocin   [administration & dosage];   Randomized
Controlled Trials as Topic;  Uterine Rupture  [etiology]
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MeSH check words
Female; Humans; Pregnancy
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